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Abstract 
Haemorrhagic septicemia  (HS), caused by the Gram-negative bacterium Pasteurella 
multocida serotype B:2, is an economically important disease responsible for morbidity 
and mortality of bovines, especially buffaloes, in countries of South or Southeast Asia 
and Africa. A feature of this disease is the rapid spread of infecting bacteria from the 
respiratory tract to the blood and lymph to cause a fatal septicemia. To pass into the 
blood stream, the bacteria must migrate through the epithelial layer into the pulmonary 
interstitium. Avian serogroup A strains of P. multocida have been reported to invade 
cultured mammalian cells, but the behaviour of other of serogroups has not been 
reported. The main object of the work was to confirm that HS strains of P. multocida 
B:2 have the capacity to invade and survive within cultured mammalian cells, such as 
J774.2 cells (mouse macrophage-like cell lines) and BL-3 cells (bovine lymphoma cell 
line). Invasion, defined as adhesion to, followed by uptake by, or entry into, J774.2 
macrophage cells or BL-3 cells was determined by: (I) counting of viable intracellular 
bacteria after killing extracellular bacteria with polymyxin and gentamicin, (II) 
Transmission electronic microscopy. Comparison of the invasiveness of a B:2 HS strain 
and its aroA derivative JRMT12 with that of P. multocida A:3 and E. coli XL1-Blue, 
showed that both P. multocida B:2 strains invaded both types of mammalian cells more 
readily than P. multocida A:3 and that E. coli XL1-Blue was essentially non-invasive. 
Both strains of P. multocida B:2 could survive within J774.2 macrophage and BL-3 cells 
for at least 2 h. A longer-term survival experiment (up to 6 h incubation) indicated that 
the numbers of intracellular bacteria declined between 4 to 6 h post-infection. It was 
shown by TEM that a significant proportion of the P. multocida B:2 bacteria were found 
  Xwithin vacuoles in the cytoplasm of the mammalian cells with some free in the 
cytoplasm. A much reduced invasion capacity of P. multocida A:3 and E. coli XL1-Blue 
was detected. Different effects on the appearance and viability of J774.2 and BL-3 cells 
were observed by the trypan blue method and TEM when exposed to the P. multocida 
B:2 strains. Evaluation of cytotoxicity of P. multocida B:2 stains with J774.2 cells by the 
MTT assay produced unsatisfactory results. 
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  XIVCHAPTER 1 
Introduction  
1.1 Family Pasteurellaceae 
    The  family  Pasteurellaceae was, until recently, comprised of 57 named bacterial 
species which have been isolated from human and various animal sources in three 
genera Haemophilus, Pasteurella and Actinobacillus (Korczak et al., 2004). At present, 
the taxonomic structure of the family Pasteurellaceae incorporates the organisms 
formerly known as [Pasteurella] haemolytica into the new genus Mannheimia (Angen et 
al., 1999), and also includes the genera Histophilus (Angen et al., 2003), Gallibacterium 
(Christensen et al., 2003), Volucribacter (Christensen et al., 2004), Nicotella (Kuhnert et 
al., 2004), Avibacterium (Blackall et al., 2005). Historically, members of the family 
Pasteurellaceae were classified on the basis of a limited number of phenotypic 
characteristics. In particular, organisms were assigned to the family on the basis of their 
requirements for the growth factors haemin and/or nicotinamide adenine dinucleotide 
and on the basis of their ability to cause disease in vertebrates (MacInnes and Borr, 
1990). Major advances in understanding the phylogeny of the members of family 
Pasteurellaceae have come from DNA-DNA hybridization and from rRNA-DNA 
hybridization studies (De Ley et al., 1990). These studies revealed that the members of 
the Pasteurellaceae were most closly related to member of the Enterobacteriaceae, the 
Vibrionaceae, the Aeromonadaceae, and the genus Alteromonas and also suggested that 
this family was very heterogeneous.  
    Members of the Pasteurellaceae are small Gram-negative rods, which are generally 
isolated from mucosal membranes and tissue of birds and mammals including, 
occasionally, man. There is a strong host association that has probably co-evolved with 
  XVthe corresponding host. While most of the species are commensals, there are a few that 
act as pathogens (Bisgaard, 1993; Mario and Mikael, 2002) (Table 1). These include the 
human pathogens Haemophilus influenzae, which causes neonatal meningitis and otitis 
media, and Actinobacillus actinomycetemcomitans, which causes juvenile periodontitis. 
Important animal diseases are caused, for example, by Mannheimia haemolytica 
(shipping fever of cattle), Pasteurella multocida (atrophic rhinitis in swine, fowl cholera, 
snuffles in rabbits and haemorrhagic septicaemia in cattle and buffaloes) and 
Actinobacillus pleuropneumoniae (pleuropneumonia in pigs) (Korczak et al., 2004).   
 
1.1.2 The genus Pasteurella 
    The genus Pasteurella has recently been investigated and the taxonomical position of 
P. multocida has been defined (Dziva et al., 2008). P. multocida is the type species of 
the genus and currently includes P. multocida subsp. multocida, P. multocida subsp. 
septica, P. multocida subsp. gallicida. These are the most frequently isolated species in 
human infections (Escande and Lion, 1993). A new subspecies of P. multocida, 
subspecies tigris, has been designated and isolated from a tiger-bite wound in a child 
(Capitini et al., 2002), but this finding has not been validated by further investigation. 
Two additional species designated Pasteurella species A and B were consider to be 
members of the genus but remain unnamed (Peter et al., 2005; Dziva et al., 2008).  The 
principle characteristics of members of the genus are that they are non-motile, Gram-
negative rods or coccobacilli, facultatively anaerobic and most species are oxidase-
positive, catalase positive, alkaline phosphatase positive, reduce nitrate and they display 
a characteristic bipolar staining with Leishman or methylene blue stains (Peter et al., 
2005).  
  XVITable 1. Members of the Pasteurellaceae family and the diseases they cause in their 
respective hosts (Mario and Mikael, 2002). 
Organism  Host  Disease 
Haemophilus       
H. ducreyi  Human  Chancroid 
H. influenzae capsular type 
B (Hib) 
Human 
Meningitis, septicaemia, and 
epiglottitis 
H. influenzae non-typable 
(NTHi) 
Human 
Otitis media, sinusitis, conjunctivitis and 
acute lower respiratory tract infection 
Actinobacillus       
A. actinomycetemcomitans  Human  Juvenile and adult periodontitis 
A. pleuropneumoniae  Swine  Pleuropneumonia 
Pasteurella       
Pasteurella (Mannheimia) 
haemolytica 
Bovines and sheep  Pneumonia 
P. multocida 
Most animals, 
occasionally 
human  
Meningitis, fowl cholera, atrophic 
rhinitis, snuffles, haemorrhagic 
septicaemia, and pneumonia  
 
 
  XVII1.1.3 The species Pasteurella multocida  
    Louis Pasteur recognized and identified this organism over 125 years ago (Harper et 
al., 2006). Members of this species are distributed throughout the world, among varieties 
of both terrestrial and aquatic species of mammals and birds (Rimler and Rhoades, 
1989). The species P. multocida now includes a heterogeneous group of Gram-negative 
bacteria that are inhabitants of the upper respiratory tract of various animals (Dziva et 
al., 2008), some of which are human pathogens causing infection of bite wounds, 
respiratory disease and infections of the central nervous system (Kristinsson, 2007). The 
organisms can occur as commensals in the naso-pharyngeal region of apparently healthy 
animals and they can be either primary or secondary pathogens in disease processes of a 
variety of domestic and wild mammals and birds (Harper et al., 2006).  
 
1.1.3.1 Cultural characteristics and colonial morphology  
    P. multocida can grow on rich laboratory media like brain heart infusion agar (BHIA), 
sheep blood agar (SBA), and chocolate agar. A suitable medium for growth of P. 
multocida is Casein Sucrose Yeast (CSY) agar containing 5% sheep blood. The 
organisms is non-haemolytic and does not grow on MacConkey’s agar (Oie, 2004; 
Shivachandra et al., 2006; Dziva et al., 2008), or other types of selective or differential 
enteric media (Peter et al., 2005). Bovine or ovine blood agar has consistently yielded 
reasonable success in isolation Pasteurella species (Dziva et al., 2008). On blood agar, 
pure colonies of P. multocida are round, grey in colour, mucoid or non-mucoid with a 
typical sweetish odour like E. coli, perhaps due to the formation of large amounts of 
indole by the organism. Major variations in colony morphology have been observed for 
P. multocida, some of which are host related (Dziva et al., 2008).  
 
  XVIII     Cultures on agar medium may develop into either of two principal colony forms, 
smooth and rough. Smooth colonies are mucoid and their characteristics can range from 
cultures whose colonies are discrete, circular, and convex and have a slight mucus-like 
consistency, to cultures whose colonies are confluent, markedly moist and viscous.   
Rough colonies, which consist of filamentous non-capsulated cells have been described 
as being flat with slightly raised central papillae and flattened, irregularly serrated edges 
or discrete, raised, circular, rough and slightly dry (Rimler and Rhoades, 1989). Mucoid 
colonies are often obtained from pneumonic lesions in cattle, pigs and rabbits whilst 
non-mucoid colonies most often are recovered from poultry.  
 
    Colonies of serogroup A, D and F strains display a pearl-like iridescence in oblique 
transmitted light while colonies of P. multocida serotype B and E are usually grey and 
viscous, small, glistening mucoid dew-drop-like colonies on blood agar plates. All are 
catalase and oxidase positive and reduce nitrate and are non-motile and non-haemolytic 
on blood agar. Glucose, fructose, galactose, mannitol, sucrose are fermented 
(Shivachandra et al., 2006).  
 
1.1.3.2 Serotype identification   
        In 1981, a standard system for the identification of P. multocida
  serotypes was 
recommended that utilized both the Carter capsular
 typing identified by the letters A, B, 
D, E and F (Carter and Chengappa, 1981), and the Heddleston
 somatic typing system 
which identified 16 different somatic types numbered 1 to 16 (Heddleston et al., 1972). 
Haemorrhagic septicaemia strains were designated as serotypes B and E (Carter, 1955), 
with a combination of Carter types and somatic antigen typing defining Asian and 
African HS strains as 6:B or 6:E, respectively (Namioka and Murata, 1961), while in the 
  XIXlatter system they are designated B:2 and E:2, respectively (Oie, 2000). The type-
specific antigen (Carter type B or E) refers to the bacterial capsule, whereas the O-group 
antigen (Heddleston type 2) refers to the lipopolysaccharide component (Shah et al., 
1996).  
 
1.2 Molecular biology of Pasteurella  
1.2.1 Pasteurella multocida genes 
    The recent application of molecular methods such as the polymerase chain reaction, 
restriction endonuclease analysis (REA), ribotyping, pulsed-field gel electrophoresis, 
gene cloning, recombinant protein expression, mutagenesis, plasmid and bacteriophage 
analysis and genomic mapping, have allowed progress towards a better understanding of 
the molecular biology of P. multocida (Gichohi, 2001). For example, REA has proved to 
be a valuable tool for investigating outbreaks of pasteurellosis. Several restriction 
enzymes have been used for DNA fingerprinting of P. multocida by REA, with HhaI 
and HpaII yielding the most informative and distinguished profiles from a wide range of 
serotypes (Hunt et al., 2000). Plasmids have been recovered from P. multocida strains 
isolated from various animal species (McGee and Bejcek, 2001). These plasmids 
conferred antibiotic resistance (R factors) as well as encoding virulence factors. For 
example, plasmids correlated to complement resistance are particularly conserved in 
avian isolates (McGee and Bejcek, 2001). Plasmid profile was considered as a virulence 
marker of P. multocida as well as an essential epidemiological tool for identifying 
different strains from the same phenotype. P. multocida can be transformed with 
plasmids by the electroporation process which subjects the bacterial cell membrane to a 
short electric shock leading to bacterial DNA uptake (Rubies et al., 2002). 
 
  XX    May et al. (2001) reported the genome sequence of P. multocida serotype A (Pm 70), 
which has a single circular chromosome of 2,257,487 base pairs and contains 2,014 
predicated protein-coding genes. Two genes resemble the filamentous haemagglutinin 
(fha) genes found in the whooping cough bacterium, Bordetella pertussis. The FHA 
protein helps the pertussis bacterium to adhere to host cells, and the P. multocida 
versions of these proteins may play a similar role, making them promising vaccine 
targets (May et al., 2001). The other striking feature of this genome is that 2.5% of the 
genes produce proteins that are predicted to be involved in transport of iron into the cell 
or its processing. Iron is an essential nutrient for nearly all organisms because of its 
presence in the electron transport chain producing ATP. In P. multocida (Pm 70), 174 
genes showed at least a two-fold change in gene expression on iron depletion; 53% 
showed a decrease in activity and 47% showed an increase. About 16 genes showing 
higher activity at low iron levels are thought, based on comparison with other 
organisms, to code for iron transport proteins (May et al., 2001).  
 
1.3 Virulence-associated factors  
    Many  members  of  Pasteurellaceae family express fimbriae at their surface, in 
addition to surface polysaccharides and outer membrane proteins, which are often 
involved in adherence to host cells (Mario and Mikael, 2002; Tomer  et al., 2004). 
However, the molecular mechanisms of P. multocida pathogenesis are still largely 
unknown, and only a few virulence factors have been identified. These factors include 
toxins, capsule, iron acquisition proteins (section 1.2.1), haemagglutinins (Boucher et 
al., 2005), lipopolysaccharide (endotoxin), fimbriae and outer-membrane proteins 
(Mullen  et al., 2007). Some organisms of this family produce haemolytic and/or 
cytotoxic protein(s) of the RTX (repeats in toxin) family, including Actinobacillus 
  XXIpleuropneumoniae and A. suis (Mario and Mikael, 2002) and Pasteurella haemolytica 
(Coote, 1992). It is thought that these factors allow P. multocida to multiply in the lungs 
of animals and contribute directly or indirectly to septicaemia. 
 
1.3.1 Capsule 
    P. multocida capsule structure has a pivotal role in the determination of the serogroup 
type of the bacteria. Polysaccharides constitute the major part of the capsule and in some 
cases they may be associated with lipoproteins. Five capsular serotypes were identified 
namely, A, B, D, E and F (Carter, 1967). The capsule lies outside the outer membrane 
and is composed of highly hydrated polyionic polysaccharides to protect against 
dehydration of the bacteria (Roberts, 1996). Virulent strains of P. multocida are usually 
capsulated and this can be seen in organisms isolated from diseased tissue and after 
laboratory culture. Several techniques have been used to demonstrate capsules for light 
microscopy. The alcian blue, Congo red and crystal violet methods have been used for 
direct staining of the capsule (Boyce et al., 2000). Presence of the capsule is assumed to 
be important for transmission of Pasteurella from host to host or for enhanced survival 
in the environment and has also been shown to have antiphagocytic activity (Boyce et 
al., 2000). The composition of the P. multocida capsule has been investigated only in 
serogroups A, B, D and F, and the chemical composition of serogroup E capsule remains 
unknown. The composition and structure of the capsular material found in P. multocida 
serotype A, D and F are very similar to mammalian glycosaminoglycans and consist 
mainly of hyaluronan, heparosan and unsulphated chondroitin, respectively (Pandit and 
Smith, 1993; Rimler and Rhoades, 1994; Boyce et al., 2000).  P. multocida serogroup B 
capsule was shown to contain fructose, mannose, glucose, glucosamine and 
polysaccharide and also to contain 0.5% protein and 1.7% nucleic acid (Boyce et al., 
  XXII2000). The complete nucleotide sequence of the capsule biosynthetic locus of P. 
multocida X-73 (A:1) and P. multocida M1404 (B:2), has been determined. The locus of 
P. multocida X-73 (A:1) consists of 11 ORFs and that of P. multocida B:2 consists of 15 
ORFs in 3 regions. Functions for the encoded proteins have been proposed for seven of 
the B:2 ORFs. Regions one and three each contain a total of six genes, involved in 
transport of polysaccharide, while region two contains nine genes which are postulated 
to be involved in the biosynthesis of polysaccharide in P. multocida B:2 (Boyce et al., 
2000).  
 
     In  addition,  Rimler  and  Rhoades  (1989) believe that the capsule antigen of P. 
multocida is associated with lipopolysaccharide (LPS), as well as non-antigenic 
polysaccharide material. However, the capsule-specific antigen and LPS can be absorbed 
onto erythrocytes from crude cell extract. Passive haemagglutination tests with serum 
containing antibodies against both the capsule-specific antigen and LPS usually show a 
reaction only with the capsule-specific antigen. The high antibody levels do not correlate 
with protection against experimental challenge (Rimler and Rhoades 1989). 
 
    Capsular variants of P. multocida serotype B have been shown to reach a lower titre in 
the blood of infected animals and have an approximately 10
5-fold higher LD50 (Snipes 
and Hirsh, 1986; Jacques et al., 1993). This indicates as important role for the capsule in 
the pathogenesis of P. multocida serotype B as capsular variants are strongly attenuated 
in mice and have increased sensitivity to phagocytosis by murine macrophages. A 
virulence assay in mice indicated that a capsular variant of P. multocida B:2 was 10
6-
fold less virulent than the encapsulated counterpart (Boyce and Adler, 2000). The 
capsule is also thought to be involved in bacterial avoidance of phagocytosis and 
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Some studies have also indicted a relationship between capsule thickness and resistance 
to phagocytosis (Harmon et al., 1991; Boyce et al., 2000). 
 
1.3.2 Lipopolysaccharide (LPS)  
    LPS, responsible for the 1-16 somatic serotypes, is a critical virulence determinant in 
P. multocida and a major antigen involved in host protective immunity. It consists of 
lipid A, a core oligosaccharide and a polysaccharide side-chain (O-antigen). In other 
mucosal pathogens, variation in LPS or lipooligosaccharide structure typically occurs in 
the outer core oligosaccharide regions due to phase variation (Harper et al., 2007). There 
are conflicting reports as to the endotoxic properties of LPS isolated from avian P. 
multocida; chicken embryos and mice are highly susceptible, but turkey poults are 
relatively resistant (Harper et al., 2006). In the HS-associated P. multocida serotype B, 
LPS is thought to be responsible for toxicity and to play an important role in the 
pathogenesis of the disease (Horadagoda et al., 2002). P. multocida B:2 bacteria 
aspirated into lungs of buffaloes prompted the appearance of LPS in the blood and 
induced a response consistent with endotoxic shock. It was concluded that LPS is a 
major virulence factor and  plays an essential role in causing HS in buffaloes 
(Horadagoda et al., 2002). Antibody reacting with the LPS of type A strains has given 
protection against murine and rabbit infection, whereas antibodies to LPS appear to play 
a subordinate role in protection with type B (Harper et al., 2006). 
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    Surface components such as capsule and outer membrane proteins have been the 
subject of a number of studies to further elucidate the pathogenic mechanisms of P. 
multocida, but adhesins of this bacterium have received little investigation.  Bacterial 
adherence to host cells or surfaces is often an essential first stage in disease; it 
localizes pathogens to an appropriate target tissue. Adhesion to host cells may result 
in internalisation; either by phagocytes or by bacterial-induced endocytosis known as 
invasion. Thus, attachment by fimbriae to host surfaces is usually correlated with 
virulence (Heckels, 1989). P. multocida is considered to colonize the nasal mucosa of 
susceptible animals. Electron microscopy has shown fimbriae on P. multocida 
serotype A harvested from rabbit pharyngeal cells, pig tonsilar and nasal cells, and 
nasal and tracheal cells of calves (Glorioso et al., 1982; Ruffolo et al., 1997). In an in 
vitro trial using newborn pigs it was shown that serogroup D bacteria were adherent to 
the turbinate area and showed fimbriae when observed by scanning electron 
microscopy (Pijoan and Trigo, 1990). Although there are no data conclusively on 
fimbriae of serogroup B, fimbriae-like filamentous appendages were observed on the 
surface of HS-causing P. multocida B:2, although further characterization of this 
structure was not undertaken (Tomer et al., 2004).  
 
1.3.4 Outer membrane proteins (OMPs) 
    The outer membrane of Gram-negative bacteria contains lipopolysaccharide, several 
minor proteins and a limited number of major proteins of 34 to 42 kDa present in very 
high copy numbers (Lee et al., 2007), some of which are generally considered to play an 
important role in pathogenesis (Bosch et al., 2004). Generally, seven such OMPs have 
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G1pQ (Coony and Lo, 1993; Kasten et al., 1995; Ruffolo and Adler, 1996; Luo et al., 
1997; Gatto et al., 2002; Lo et al., 2004). OMP profiling also offers a relatively quick 
way to establish relationship between strains. OmpH and a heat-modifiable OMP of P. 
multocida (OmpA) have provided an OMP typing scheme. Based on the electrophoretic 
separation of these 2 major OMPs and other minor ones, Davies et al. (2003) 
demonstrated up to 19 OMP types among avian strains of P. multocida serotype A. High 
resolution OmpA and OmpH profiling of bovine isolates from England and Wales 
revealed no correlation with disease-status or geographic origin (Davies et al., 2004). It 
has been suggested that OMP profiling could provide a non-serological technique for 
identifying HS strains of P. multocida (Dziva et al., 2008). Several studies have 
indicated that OMPs of P. multocida 6:B were involved in resistance to phagocytosis by 
murine peritoneal macrophages and possessed immunogenic properties (De Alwis, 
1990a; Srivastava, 1998; Basagoudanavar et al., 2006). A recent study investigated the 
generation of immune responses to OMPs in cattle and in buffaloes and revealed that 
OMPs of P. multocida may be important contributors to the pathogenic potential of 
disease-causing bacteria and possesses immunogenic properties that might be useful in 
vaccines against HS (Basagoudanavar et al., 2006). 
    The Pm 70 genome sequence identified genes for putative haemoglobin and haemin 
binding proteins, such as a heme acquisition system receptor homologue, suggesting that 
P. multocida might also use free haemin as an iron source (Bosch et al., 2004). Iron is 
essential for bacterial growth and replication as well as for establishment of infection. P. 
multocida serotype B:2,5 strains have been shown to produce transferrin-binding 
membrane proteins (Tbp1 and Tbp2) (Veken et al., 1994). An 82-kDa iron-regulated 
OMP was found which specifically binds bovine transferrin. Iron-regulated OMPs of P. 
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immunity against pasteurellosis (Basagoudanavar et al., 2006). The composition of the 
P. multocida outer membrane varies only marginally upon infection of the host, 
suggesting that most surface components involved in pathogenesis are either expressed 
constitutively, up-regulated only during the early stage of infection or that their change 
in expression is below current detection limits (Ratledge and Dover, 2000).  
 
1.3.5 P. multocida toxins 
    Most  P. multocida strains are not known to express toxins, with the only well-
characterized toxin found in serogroup D strains (Rimler and Brogden, 1986). The 
Pasteurella multocida toxin (PMT) is generally thought to be responsible for the clinical 
and pathological aspects of atrophic rhinitis (Kamp and Kimman, 1988; Chanter, 1990), 
and inhibits osteoblast differentiation and bone formation. Inhibition of the bone nodule 
formation by PMT requires the activation of the Rho GTPase (Harmey et al., 2004), but 
it is not yet known exactly how PMT influences Rho-dependent signaling, although Rho 
is not a direct target of PMT (Oswald et al., 2005). PMT independently stimulates at 
least two different signalling pathways through the heterotrimeric GTPase Gq and the 
small GTPase Rho.  
 
    P. multocida serogroup A (X-70) and serogroup B toxicity on host cells has been 
reported. The toxic activity of HS strains of P. multocida serotype B was examined in a 
mouse model. The mice were injected intraperitoneally with 10
2 cells of P. multocida 
B:2,5.  After 6 h, the experiment revealed strong induction of cytoplasmic vacuolation in 
peritoneal macrophages. Additional in vitro experiments with a macrophage cell line, 
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macrophage vacuolation was associated only with serogroup B and E HS strains (Shah 
et al., 1996). When P. multocida A X-70 was used to infect Acanthamoeba polyphaga or 
Hartmanella vermiformis trophozoites, the bacteria were found to be located 
intracellularly when examined via transmission electron microscopy. The P. multocida 
cells were visualized in membrane-bound vacuoles within the cytoplasm of the amoebal 
cells. Within the vacuoles, bacteria divided, then lysed and exited their amoeba hosts. 
There was a large decrease in the percentage of viable host cells (1.6% viable) at 18 h 
post-infection, compared to amoeba incubated in the absence of P. multocida (33% 
viable) (Hundt and Ruffolo, 2005).  
 
1.4 Invasion of mammalian cells by bacteria  
1.4.1 Interaction between eukaryotic cells and bacteria   
    The first specific interaction between a pathogenic micro-organism and its host entails 
attachment to the eukaryotic cell surface which may result in internalisation, either by 
phagocytic or by bacterially-induced endocytosis, a process known as invasion (Falkow 
et al., 1992). Invasive bacteria seem to have evolved two major types of uptake. First, 
there is the Zipper mechanism that involves contact between bacterial ligands and 
cellular receptors, a system used by Yersinia and Listeria (Figure 1). Y. enterocolitica 
and Y. pseudotuberculosis have an outer membrane protein, invasin, that mediates entry 
into epithelial cells by binding tightly to a ß1 integrin on the cell surface. Invasin 
mediates bacterial uptake by zippering the host cell membrane around the bacterium as it 
enters (Brett and Cossart, 1997). The intracytoplasmic domain of the ß1 integrin interacts 
with the cytoskeleton by binding to actin-binding proteins such as talin and α- actinin.  
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Figure 1: Zipper mechanism of bacterial cell entry into mammalian cells  
Yersinia has an outer membrane protein, invasin, which mediates attachment and entry 
into epithelial cells by binding to a ß1 integrin on the cell surface. This integrin interacts 
with the cytoskeleton by binding to α-actinin that contributes to internalisation. For 
Listeria, E-cadherin is a transmembrane cell adhesion protein, which through a complex 
with internalin and catenins involved in homophilic cell-cell interactions, activates   
phosphate: dlyinosit 3-kinase (PI 3-kinase) that mediates uptake by an  unknown 
mechanism (Brett and Cossart, 1997). 
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and  Shigella, where bacteria send signals to the cells to induce membrane and 
cytoskeletal rearrangement, allowing virtually passive entry of bacteria (Brett and 
Cossart, 1997) (Figure 2). Both processes ultimately use the actin cytoskeleton to 
produce pseudopod extension, and thus the signalling mechanisms are likely to converge 
at some point (Swanson and Baer, 1995). The Zipper mechanism produces a small 
pseudopod relative to the particles, and the trigger mechanism elicits a large one. 
Secretion systems are known to play a central role in bacteria and host cell interaction 
(Oswald et al., 2005). Invasion of Salmonella and Shigella into cultured cells are similar 
and both species use type III secretion systems to directly inject signaling proteins into 
target cells (Ogawa and Sasakawa, 2006). A type III secretion system is one in which the 
bacterium produces pore-forming proteins that create a pore spanning not only the 
bacterium's cytoplasmic membrane and outer membrane, but also the plasma membrane 
of the host cell. This allows the bacterium to deliver proteins directly from its cytoplasm 
into the cytoplasm of the host cell (Preston, 2007).  
 
     When Shigella contacts the epithelial cells of the colon, the type III secretion system 
delivers proteins such as IpaA (70 kDa), IpaB (62 kDa), IpaC (42 kDa) and IpD (37 
kDa) (Sansonetti, 1998), into the epithelial cells enabling them to polymerise and 
depolymerise actin filaments (see legend to Figure 2). The cytoskeleton rearrangement is 
a key part of the pseudopod formation in phagocytic cells and enables phagocytes to 
engulf bacteria and place them in a vacuole (Coburn et al., 2007). Ipa proteins have no 
signal peptide; upon contact of the bacterium with the cell surface, they are secreted, 
already folded, from the cytoplasm to the extracellular milieu without a periplasmic 
phase. In the extracellular medium, IpaB and IpaC form a complex (Sansonetti, 1998).  
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Figure 2: Trigger mechanism of bacterial invasion. 
In Shigella, the mxi-spa secretion system and other secreted proteins (IpaA, -B, -C, -D), 
activate a host-signalling pathway resulting in bacterial uptake. Cortactin is an actin-
associated protein and a substrate for the non-receptor tyrosine kinase Scr, which 
induces membrane ruffles. T-plastin appears to play a central role in mediating bacterial 
uptake, possibly by bundling newly formed actin filaments in the membrane extension. 
Another actin-binding protein, vinculin, colonizes to the site of entry and can be 
coimmunoprecipitated with IpaA.  
Image was taken from (http://www.ncbi.nlm.nih.gov/pubmed/9115192). 
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type III secretory apparatus composed of about 20 different proteins called Mxi-Spa 
(membrane expression of antigens and secretion of protein antigens) which bridges the 
inner and outer membrane. Thus, in these examples, the bacterium is able to trick the 
epithelial cell into behaving like a phagocyte and engulfing the bacterium. The bacteria 
can then cause the vacuole membrane to rupture and escape into the cytoplasm were 
they begin to multiply. 
 
1.4.2 Invasion and intracellular survival of P. multocida   
    P. multocida was, until recently, generally considered to be an extracellular pathogen 
associated predominantly with the respiratory tract of animal and human disease. 
However, a number of studies have shown that P. multocida may be found 
intracellularly within a variety of eukaryotic cells. For example, in an early study it was 
shown that P. multocida could multiply intracellularly in liver and spleens of 
experimentally infected turkeys at early stages of infection and then spread to the blood 
(Pabs-Garnon and Soltys, 1971). After intravenous inoculation of P. multocida 
serogroup A into turkeys, the number of P. multocida increased over 100 times in the 
liver and 75 times in the spleen 3 h after inoculation, but there was no increase in the 
blood. It was found that an increase in the number of organisms in the blood occurred 
rapidly between 22 and 28 hours after inoculation when the number of bacteria in the 
liver and spleen reached its peak. It appears that the bacteria from the liver and spleen 
invaded the blood before the death of the turkeys (Pabs-Garnon and Soltys, 1971). 
    Two serotype A:3,4 strains of Pasteurella that differed in virulence in turkeys were 
examined for their ability to adhere and invade different epithelial cell monolayers 
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in comparable numbers but only the virulent strain was able to invade turkey cells, as 
well as porcine epithelial cells and feline epithelial cells in cell culture. Neither organism 
invaded rabbit epithelial cells (Lee et al., 1994). This study was based on the gentamicin 
protection assay and consisted of enumerating intracellular bacteria by their resistance to 
the gentamicin-killing step of the assay, since it is expected that this antibiotic does not 
penetrate epithelial cells. In another study, the interaction of P. multocida serotype A:3 
with turkey air sac macrophages (ASM) in culture was investigated and showed that the 
bacteria were capable of adhering in large numbers to the macrophages but were not 
internalized (Pruimboom, 1996). This author also showed that adherence of P. multocida 
A to these cells was mediated by capsular hyaluronic acid (Pruimboom et al., 1996; 
Pruimboom et al., 1999). P. multocida A:3 strain P1059 was shown to adhere to and 
invade polarized epithelial Madin-Darby canine kidney (MDCK) cells by interacting 
with host F-actin (Rabier et al., 1997). Bacteria were located inside the cells near the 
apical border by 30 min after exposure and were detected by confocal microscopy. This 
study demonstrated that bacteria appeared to enter cells by association with host actin. 
Treatment of MDCK cells with cytochalasin D for either 30 min or 24 h prior to 
infection disrupted the actin cytoskeleton and inhibited entry of P. multocida (Rabier et 
al., 1997).  
 
     Association and invasion of bovine aortic endothelial cells (BAECs) by P. multocida 
B and P. haemolytica serotype A1 has also been studied utilizing the bacteria: cell ratio 
100:1 and 50µg/ml of gentamicin to kill extracellular bacteria (Galdiero et al., 2001). 
Electron microscopy demonstrated that both species were able to adhere to BAECs but it 
was reported that only P. multocida invaded BAECs while P. haemolytica was non-
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compared to the 2 and 4 h time points of invasion. The mammalian cell viability was 
checked by the lactate dehydrogenase (LDH) cytotoxicity assay, and it was reported that 
the cells were healthy after exposure to the bacteria (Galdiero et al., 2001). Some 
preliminary work examined uptake of P. multocida B:2 85020 wild-type and an aroA 
derivative JRMT12 into J774.2 macrophage-like cells at a  bacteria/cells ratio 500:1 
(Tabatabaei, 2000). This study used the antibiotics gentamicin and polymyxin B, each at 
a final concentration 350 µg/ml, to kill all extracellular bacteria. The results indicated 
that both strains were taken up into the cells and were able to survive for at least 2 h in 
the phagocytic cells. 
 
1.5 Distribution and disease association  
    P. multocida (multocida literally meaning many killing) is a pathogen which causes 
disease of economic importance in a wide range of animals and can be the primary or 
secondary agent in the disease process. Often they are inhabitants of the upper 
respiratory tract of many vertebrate hosts including birds, cattle, swine, cats, dogs and 
rodents. Members of this species are responsible for a number of infections that 
normally are secondary to colonization of the upper respiratory tract, including avian 
cholera (in waterfowl, chickens and turkeys) caused by strains of serogroup A (Hirsh 
and Tim, 1990), respiratory disease and hemorrhagic septicaemias in ruminants (cattle, 
sheep, goats and buffaloes) caused by strains of serogroups A, B or E (De Alwis et al., 
1980), atrophic rhinitis in pigs and snuffles/septicaemias in rodents (mice and rabbits) 
caused by strains usually of serogroup D. These infections are primarily transmitted by 
the respiratory route and associated with crowding and other stressors. The pathogenicity 
of P. multocida serogroup F is associated with avian hosts (Haase et al., 2006) and 
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normally associated with dog or cat bites or scratches (Haase et al., 2006). The human 
infections are characterized by rapid development of pain, erythema, swelling, cellulitis 
with or without abscess formation, and purulent or serosanguinous drainage at the 
wound site (Westling et al., 2000).  
 
1.5.1 Bovine respiratory disease (BRD) 
        BRD is a highly infectious disease, primarily of cattle, affecting the lungs and 
occasionally the joints. Two bacteria, Mannheimia (Pasteurella) haemolytica type A1 
and P. multocida serotype A, are generally associated with BRD or shipping fever in 
cattle and are often referred to as secondary bacterial invaders (Lillie, 1974; Irsik, 2007). 
These two bacteria are considered as part of the normal bacterial flora found in the upper 
respiratory tract of most cattle. Respiratory tract infections (pneumonic pasteurellosis) 
due to these two bacteria occur when the organism is inhaled. Under conditions of 
impaired pulmonary defences, a severe necrotizing pleuropneumonia develops. Spread 
of these organisms is by direct contact, or by ingestion of feed and water contaminated 
by nasal and oral discharges from infected cattle. Therefore P. multocida and M. 
haemolytica are easily spread between cattle, especially when calves are crowded (as in 
shipment) or closely confined (as in a dairy calf nursery) (Irsik, 2007). Pneumonia 
associated with either M. haemolytica or P. multocida often occurs when the animal's 
normal defences are compromised. It is possible that viruses, such as parainfluenza virus 
PI-3, play some role in shipping fever (Lillie, 1974; Mawhinney and Burrows, 2005; 
Irsik, 2007). The compromised defence mechanisms are thought to include damage to 
the cells lining the upper respiratory tract by viruses such as infectious bovine 
rhinotracheitis virus (IBR), PI-3, or bovine respiratory syncytial virus (BRSV). Damage 
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dust. The respiratory defence mechanism could also be depressed due to 
immunosuppression associated with bovine viral diarrhoea (BVD) virus (Potgieter, 
1997). The production of mucosal antibodies against the bacteria could be suppressed 
due to environmental or nutritional stress. When this defence is compromised, the 
bacteria become attached to and colonise the lining of the respiratory tract, reproduce 
rapidly and spread throughout the lungs. The clinical signs include lung damage 
associated with increased coughing and rapid breathing (Dowling et al., 2002).  
 
1.5.2 Fowl cholera (FC) 
    FC is a serious disease of poultry and can present in either acute or chronic forms. It is 
mainly caused by P. multocida serotypes A and F but, although P. multocida subspecies 
multocida is the most common cause of fowl cholera, P. multocida subspecies septica 
and gallicida may also cause the disease to some extent (Christensen and Bisgaard, 
2000). In birds, it is widely believed that P. multocida enters the host via the respiratory 
tract. Rhoades and Rimler (1990) have demonstrated adhesion of P. multocida to turkey 
air sac macrophages. Although FC is considered a septicaemic infection, bacteria can 
only be isolated in large numbers from the blood of birds very late in infection, and it 
has been proposed that this late emergence of blood-borne bacteria is due to the rupture 
of liver and spleen phagocytes (Pabs-Garnon and Soltys, 1971; Harper et al., 2006). 
Virulent P. multocida inoculated into the upper respiratory tract or trachea of turkeys can 
be subsequently detected in internal organs between 6 and 12 h post infection (Rhoades 
and Rimler, 1990). Obvious clinical signs of acute FC include facial oedema, swollen 
and oedematous wattles and combs, severe respiratory disorders, ruffled feathers, fever, 
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(Harper et al., 2006; Woo and Kim, 2006).  
 
1.5.3 Atrophic rhinitis (AR) 
     AR is a disease that profoundly affects the bone structure of the porcine snout. The 
aetiological agent currently considered to be the cause of growth retarding progressive 
AR is a toxigenic strain of capsular type D which colonizes the nasal cavity of pigs 
(Eamens et al., 1988; Foged et al., 1988). The pathological effects of P. multocida 
infection may be ascribed to the PMT toxin (see section 1.2.5) produced by this 
bacterium which is also known as dermonecrotic toxin (Foged, 1992). The toxin induces 
resorption of the nasal turbinates and other bone structures in the nasal cavity and 
impairs osteoblast bone formation (Foged, 1992; Magyar et al., 2003). There are a 
variety of factors that pre-dispose animals to developing AR, including co-infection with 
Bordetella bronchiseptica. In pigs, the severe respiratory disease can be induced 
experimentally with P. multocida infection alone, and it is now accepted that in the 
naturally-occurring disease, the pivotal role for infection with B. bronchiseptica is to 
facilitate colonisation by P. multocida (Jordan and Roe, 2004). The disease is 
characterized by other symptoms including sneezing, nasal discharge, pneumonia, and 
reduced growth rates (Rutter, 1985). 
 
1.5.4 Haemorrhagic septicaemia (HS) 
1.5.4.1 The disease  
    HS is an acute fatal disease, mainly of cattle and buffaloes, that is of great economic 
importance particularly in south-east Asia, the Middle East and some regions of Africa 
(de Alwis et al., 1990). It is a primary pasteurellosis characterised by a terminal 
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prevalent in Asia, or by serotype E:2, which has been reported only in Africa 
(Wijewardana, 1992). The disease is spread by direct and indirect contact; the source of 
infection is infected animals or carriers (Oie, 2000). Studies have shown that the carrier 
status is usually involved in disease outbreaks and the offending bacterium can be 
transmitted to other animals (Hiramune  and De Alwis 1982). The carriers are identified 
by either the presence of the organism in the nasopharynx or the organism is detectable 
in the lymphoid organs of the upper respiratory tract (Hiramune  and De Alwis 1982). 
The tonsils are the most consistent site for the persistence of the organism in a carrier 
state in cattle (De Alwis  and Wijewardana 1990; Wijewardana, 1992). Under stressful 
conditions, such as inclement weather, overcrowding and transportation, carriers are 
believed to transmit the organism to susceptible animals, which leads to outbreaks of HS 
(De Alwis et al., 1990b).  
 
1.5.4.2 Pathogenesis 
    It is not known where the organism lodges and multiplies during the early clinical 
phase of HS, but a feature of the disease is the rapid spread of infecting bacteria from the 
respiratory tract to the blood and lymph that causes a fatal septicaemia in less than 48 h. 
The bacteria must migrate through the epithelial layer into the pulmonary interstitium 
(Shah et al., 1996; Tabatabaei et al., 2002). It has been observed that virulence of the 
organism is correlated with the production of hyaluronidase although it is not known 
whether or how this is connected with pathogenesis (Wijewardana, 1992). Endotoxin 
(LPS) on the other hand is believed to play a role in the production of the pathological 
lesions and death (Wijewardana, 1992). HS-causing bacteria aspirated into the lung of 
buffaloes can lead to the appearance of LPS in the blood and can induce a systemic 
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This endotoxaemia would seem to be a major factor in the pathogenesis of HS in 
buffaloes (Horadagoda et al., 2002).  
 
1.5.4.4 Clinical presentation 
    Some characteristics and clinical features aid in the recognition of HS. The clinical 
signs of the typical disease caused by P. multocida B:2 or E2 strains include a rise in 
temperature, respiratory distress with nasal discharge, frothing from the mouth, which 
leads to recumbency and death (Oie, 2004). The majority of cases in cattle and buffaloes 
are acute or peracute, with death occurring from 6-24 h after the first recognized signs 
(Benkirane  and De Alwis 2002). In most cases, there is an oedematous swelling of the 
head, neck, and brisket region. Incision of the swelling reveals a clear or straw-coloured 
serous fluid (Oie, 2004).  
 
1.5.4.3 Epidemiology  
    HS is endemic in most tropical areas, including Asia, Africa, China, India, Indonesia, 
Mongolia, Myanmar, Philippines, Sri Lanka and Malaysia and causes high mortality in 
the major susceptible animal species, cattle and water buffaloes. Pigs, sheep, goats, deer 
and camel are also susceptible to infection and disease (Blackall et al., 2000) and deer 
with septicaemic disease have been identified in the United Kingdom (Pedersen et al., 
2003). There is some evidence that buffalo are more susceptible than cattle and that, in 
both species, young adult animals are more susceptible than older animals (De Alwis, 
1990b). Higher incidence of HS is associated with moist, humid conditions (Benkirane 
and De Alwis, 2002). In the United States, the disease has been confirmed only in 
American bison.  The disease is thought to be endemic in one large herd of North 
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and 1965. A P. multocida isolate from the 1922 outbreak, a serotype B:2, is maintained 
in the USDA culture collection as a reference strain. Although outbreaks of HS have 
been reported in sheep and swine, it is not a frequent or significant disease. Cases have 
been reported in deer, elephants and yaks. There is as yet no evidence of a reservoir of 
infection outside the principal hosts: cattle, water buffaloes, and bison (Oie, 2004).  
    Outbreaks can occur at all times of the year but those occurring during the wet season 
tend to spread, presumably due to the longer survival of the organisms under moist 
conditions (Oie, 2004). Outbreaks are usually correlated with the onset of rain, which is 
normally preceeded by a long dry period with limited food. These adverse climatic 
factors and accompanying nutritional deficiencies may well precipitate the activation of 
the carrier to become a source of infection for susceptible animals.  
 
1.5.4.5 Diagnosis  
    To identify HS-causing organisms, a wide range of laboratory diagnostic tests have 
been developed which mainly include culture on specific media such as Blood Agar 
(BA) or on Brain Heart Infusion Agar (BHIA), and biological tests after isolation of the 
causative agent. Freshly isolated colonies on Casein Sucrose Yeast (CSY) agar enriched 
with blood are approximately 2 mm in diameter after 24 h at 37ºC (Wijewardana, 1992). 
Serological tests have been also employed, e.g. rapid slide agglutination tests or agar gel 
precipitation tests. An ELISA test using a live or formalin-inactivated suspension of P. 
multocida as coating antigen was developed. Regardless of the capsular serogroup 
associated with HS, the assay was reported to have a specificity of 99% and a sensitivity 
of at least 86% (Dziva et al., 2008). Molecular methods such as PCR, ribotyping or 
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rapid and enable strain differentiation within serotypes and hence some epidemiological 
inferences, for investigations extending beyond routine diagnosis (Benkirane and De 
Alwis, 2002).  
 
1.5.4.6 Treatment  
    HS is a primary bacterial disease and, theoretically, could be effectively treated by the 
wide range of antibiotics currently available. However, treatment is constrained by a 
host of practical considerations. Animals can be cured only if they have been treated in 
the very early stages of the disease (Benkirane and De Alwis 2002). Early detection and 
effective treatment are achieved through regular checking of rectal temperatures of in 
contact animals. Usually, chemotherapy relies on either streptomycin or oxytetracycline 
administrated by the intramuscular route at fairly high dosage (Benkirane and De Alwis 
2002). Antibiotic resistance has been reported for streptomycin and sulphonamide in 
some strains of P. multocida, but it was not reported for the HS serotypes (De Alwis, 
1992).   
 
1.5.4.7 Prevention and control  
    The best way to prevent HS in cattle and buffaloes is vaccination. It is a major control 
measure and various vaccine types have been developed, including broth bacterin, oil 
adjuvanted vaccines, alum-precipitated vaccines, the double emulsion vaccine and a live 
vaccine (Verma and Jaiswal, 1998). The most effective bacterin is the oil-adjuvant 
vaccine where one dose provides protection for 9-12 month  so it needs to be 
administered annually (Verma and Jaiswal, 1998; Tabatabaei et al., 2002). The alum-
precipitated bacterin needs to be given twice yearly and this vaccine appears to be the 
  XLImost popularly used in Asia.  Both bacterins have the disadvantage of conferring an 
immunity of short duration, and the potential to cause endotoxic shock when high 
density bacterins are used (Wijewardana, 1992).  
 
    The  immunoprotective  efficacy  of  P. multocida 6:B OMPs was examined in the 
mouse model. Prototype vaccines were prepared using OMPs with adjuvants including 
dioleoyl phosphatidyl choline-based liposomes and Montanide ISA206 water-in oil-in 
water emulsion. Antibody response to the vaccine was monitored using an indirect 
ELISA test. This study showed that immunized mice had a high titre of antibodies with 
both of the formulations. The vaccinated mice were able to survive a live virulent 
bacterial challenge. Based on the findings of the study it can be inferred that OMPs are 
important determinants of immunoprotection, hence can serve as vaccine candidates 
against haemorrhagic septicaemia (Basagoudanavar et al., 2006). 
 
    A number of attempts have been made to create live, attenuated vaccines for HS, 
including a number of streptomycin-dependent (Str
D) mutants of HS-causing P. 
multocida B:2 obtained from Sri Lanka. These mutants were avirulent for mice, when 
inoculated alone, but some mutants killed mice when inoculated with streptomycin. 
Although most of the mutants were stable, some of them produced streptomycin-
independent revertants. It was shown that the rate of reversion varied between different 
mutants and most of them were highly virulent for mice (De Alwis et al., 1980). A  P. 
multocida serotype B:3,4 was isolated from a fallow deer (Dama dama) in England after 
an outbreak of septicaemic disease (Jones and Hussaini, 1982). It was reported to have a 
low virulence for cattle possibly due to the lack of transferrin-binding proteins (Veken et 
al., 1994). It has also been used as an exprimental live vaccine, containing 2 x 10
7 viable 
  XLIIorganisms per dose, in cattle and buffaloes. The strain was able to raise antibodies in 
cattle that protected mice against serotype B infections. Six months after immunization, 
the vaccine was reported to be more efficacious than an alume-precipitated vaccine in 
protecting calves against B:2 challenge (Myint et al., 1987). A capsular mutant (AL18) 
of P. multocida B:2 has been constructed by inactivation of the bcbH gene (a gene 
predicted to be involved in polysaccharide biosynthesis). Immunisation of mice with the 
mutant was able to confer significant protection against wild-type challenge, while 
immunisation with similar doses of either killed wild-type or killed mutant failed to 
confer protection (Boyce & Adler, 2001).  
 
    Other live vaccines have been based on aroA mutants of P. multocida strains. The 
aroA gene encodes 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase, which is 
involved in the conversion of shikimic acid to chorismic acid, an intermediate common 
to the biosynthesis of aromatic amino acids L-tryptophan, L—tyrosine and L-
phenylalanine. Mutation in the aroA gene creates dependence for growth on aromatic 
compounds that are not available in the host, as this pathway is not operative in 
mammalian cells (Tabatabaei et al., 2002). The aroA strains derived from P. multocida 
serotype A:1 (PMP1) and P. multocida serotype A:3 (PMP3), when tested for virulence 
in a mouse model, both showed high attenuation and were able to protect mice against a 
lethal parental strain challenge (Homchampa et al., 1992). These strains were also 
shown to provide protection against challenge in chickens (Scott et al., 1999). A marker 
free aroA deletion derivative (strain JMRT12) of a virulent field isolate of P. multocida 
B:2 (strain 85020) obtained from Sri Lanka was created which was highly attenuated in 
a mouse model of HS (Tabatabaei et al., 2002). Mice infected with HS-associated wild-
type P. multocida B:2 showed that the LD50 varied according to the different routes of 
  XLIIIchallenge. The dose of P. multocida 85020 which killed 50% of inoculated animals were 
given by the intraperitoneal (IP) route was <20 CFU/ mouse, whereas when delivered by 
the intranasal IN route there was 10
3 CFU/mouse (Tabatabaei et al., 2002). 
Intraperitoneal injection of mice with 1 CFU per mouse of the P. multocida 85020 
parent strain killed 2 of 3 mice but 2.6 x 10
7 CFU of the mutant did not kill any of them 
(Tabatabaei et al., 2002). It was shown that a single immunization by the intramascular 
route with the JMRT12 aroA strain was able to create complete protection against 
subsequent homologous challenge in the mouse model with up to 1000 LD50 of the 
parent strain. Further work with the aroA strains undertaken in calves (Hodgson et al., 
2005; Dagleish et al., 2007) showed that intramuscular injection twice of 10
7, 10
8 or 10
9 
CFU twice at a 4-week interval of the aroA strain JRMT12 completely protected calves 
against challenge with the virulent parent 85020 strain.  
 
 
1.6 Host defences  
    The phagocytes of the innate immune system provide a first line of defence against 
many common microorganisms and are essential for the control of common bacterial 
infections (Leon and Ardavin, 2008). However they cannot always eliminate infectious 
organisms, and lymphocytes of the adaptive immune system have evolved to provide a 
more versatile means of defence that, in addition, provides an increased level of 
protection from a subsequent re-infection with the same pathogen. The cells of the innate 
immune system play a crucial part in the initiation and subsequent direction of the 
adaptive immune responses. Moreover, because there is a delay of 4-7 days before the 
initial adaptive immune response takes effect, the innate immune response has a critical 
role in controlling infections during this period (Charles  et al., 1999).  
  XLIV    Natural acquired immunity to HS was described in 1980 (De Alwis and Carter 1980). 
In Sri Lanka, where high, moderate and low HS incidence areas can be identified, the 
naturally acquired immunity comes from sub-clinical infection. De Alwis (1982) 
reported that when susceptible buffalo calves were exposed to natural infection with the 
HS agent, some calves succumbed to disease while the others developed varying degrees 
of immunity which in most instances is considerably higher than that induced by 
vaccination. Immunity was attributed to protective antibodies that develop following 
non-fatal exposure and can persist for more than one year in some animals.  
 
1.7 Aim of this study 
    The goal of the present study was to study the internalization of HS strains of P. 
multocida  B:2 by mammalian cells and to determine the fate of intracellular P. 
multocida B:2. If P. multocida B:2 can survive in J774.2 macrophage like cell lines or 
BL-3 bovine lymphoma cell lines, can they proliferate within these cell lines and destroy 
the cells? 
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Materials and methods:  
 
2.1 Bacterial strains 
Two strains of Pasteurella multocida serotype B:2 were used: strain 85020 wild type 
was originally imported from Sri Lanka under licence PO/95/22, and an aroA deletion 
derivative 85020 of this strain was created by allelic exchange (Tabatabaei et al., 2002). 
Escherichia coli XL1-Blue (Stratagene), and Pasteurella multocida serogroup A:3 
(Supplied by Dr. J.C. Hodgson, Moredun Research Institute, Edinburgh) were also used 
(Table 2).  
 
2.1.1 Growth media and sterilisation  
Bacteria were grown on brain heart infusion broth (BHIB, Oxoid) (Appendix 5.1), brain 
heart infusion agar (BHIA) or BHIA supplemented with 5% (v/v) defibrinated sheep 
blood (E&O Laboratories, Scotland) (SBA) (Appendix 5.1). All the culture media were 
sterilised by autoclaving at 15 p.s.i (121°C) for 15 min.  
 
2.1.2 Storage of isolates 
All strains were stored frozen at -80°C in BHI containing 50% (v/v) glycerol. P. 
multocida strains from the frozen glycerol stocks were subcultured routinely on SBA at 
37ºC. 
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Table 2:  Bacterial strains used to investigate the adherence to and invasion of mammalian cells. 
 
 
Strain  Origin  Source 
Pasteurella multocida serotype B:2 (85020)  Bovine haemorrhagic septicaemia 
Sri Lanka  
Division of Infection and Immunity, University of 
Glasgow (Dr. Coote). 
JRMT12 (an aroA derivative of Pasteurella 
multocida B:2 85020). 
Created by allelic exchange 
(Tabatabaei et al., 2002). 
Division of Infection and Immunity, University of 
Glasgow (Dr. Coote). 
Pasteurella multocida serotype A3 (MRI, 
671/90) 
Bovine pneumonia 
Scotland 
Moredun Research Institute (Dr. J. Hodgson). 
Escherichia coli XL1-Blue genotype: endA1, 
gyrA96 (Nal
R), thi-1, recA1, relA1, lac, glnV44, 
F'[ :Tn10 proAB
+ lacI
q ∆(lacZ)M15] hsdR17(rK
- 
mK
+) 
  Stratagene. 
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2.1.3 Culture purity checks  
Bacterial colonies from all agar plates and broth cultures were subjected to purity checks 
by Gram staining and by culture on SBA or BHIA and, after incubation at 37ºC for 24 h, 
checked for purity of colony growth. 
 
2.2 Antibiotics   
The following antibiotics were used: polymyxin B sulphate (PB) (Sigma) and 
gentamicin (GM) (Sigma) at a final concentration of (350 µg/ml) each. Antibiotics were 
dissolved in distilled water at 350 mg/ml as stock solutions, sterilised by passage 
through a 0.2 µm membrane (Sartorius, Germany) and stored frozen at -20°C. 
 
2.3 Preparation of bacterial inocula and growth curves 
P. multocida B:2 85020 wild type and the aroA derivative of this strain (JRMT12) were 
used. A loopful of bacteria was taken from a stock culture of P. multocida that had been 
maintained at -80°C and plated onto SBA. After incubation overnight at 37°C, a single 
bacterial colony was added to 25 ml of BHIB and grown overnight at 37°C in an orbital 
incubator set at 150 r.p.m. Then, 0.5 ml of this culture was inoculated into 25 ml of pre-
warmed BHIB and the OD at 600 nm measured at intervals. 
 
2.4 Bacterial viability measurements  
It was necessary to confirm that the conditions used in the antibiotics assay for 
intracellular survival were sufficient to eliminate the extracellular bacteria. A 1.0 ml 
inoculum from an overnight culture in BHIB was introduced into a flask containing 20 
  Iml of BHIB and incubated for 4 h (log-phase) at 37°C in an orbital incubator at 150 
r.p.m. After centrifugation at 3,000 x g for 30 min, the cells were resuspended in 10 ml 
of RPMI 1640 medium (Gibco) containing 1 ml L-glutamine (Gibco), 20 ml of foetal 
calf serum (Gibco) and diluted in the same medium to give a bacterial concentration of 
10
5 CFU/ml. Gentamicin and polymyxin B sulphate (Appendix 5.6) were added to a 
final concentration of 350 µg/ml, either separately or together, and, after 0, 60, and 120 
min of incubation, samples were removed and dilutions were plated onto BHIA and the 
number of colonies was determined after 24 h of incubation at 37°C.  
 
2.5 Mammalian cell lines 
J774.2 murine macrophage like cells and BL-3 bovine leukaemia-derived lymphoma 
cells were used in this work (provided by Dr John Coote, University of Glasgow, 
Infection and Immunity Division).  
 
2.5.1 J774.2 cells  
J774.2 cells were maintained in 20 ml of RPMI 1640 (Gibco) medium supplemented 
with 1 ml L-glutamine (Gibco), 1 ml foetal calf serum (Gibco) and 1 ml antibiotic 
solution (Gibco) (complete medium) (Appendix 5.4) at 37°C, in an air atmosphere of 5% 
CO2, 95% under controlled humidity. One flask was used to seed three flasks and this 
produced confluent growth within 48-72 h. The numbers of viable cells was determined 
by counting trypan blue-excluding cells in a haemocytometer (Section 2.6). Loss of cell 
viability was estimated microscopically by noting the number of dead cells taking up the 
dye, expressed as a percentage of the total cell count (section 2.6). 
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2.5.2 BL-3 cells  
BL-3 cells were grown in suspension culture in a medium (BL-3 medium) (Appendix 
5.5) containing 50 ml L-15 Leibovitz medium (Gibco), 50 ml RPMI 1640 medium 
(Gibco) with 20 ml foetal bovine serum (Gibco), 1 ml L- glutamine (Gibco), and 1 ml 
penicillin and streptomycin solution (Gibco) at 37ºC in an atmosphere of 5% CO2 95% 
air under controlled humidity. Cells were split 1:5 in the above medium and grown for a 
further 4 days. Cultures were centrifuged at 1000-x g at room temperature for 5 min, the 
supernatant was discarded and the cells were resuspended in 5 ml of fresh complete BL-
3 medium, using 1 ml of cells to 10 ml of fresh medium. Cells were then incubated for a 
further 72 h at 37ºC in a 5% CO2 incubator. Viable cell numbers were determined by 
trypan blue exclusion (see section 2.6). 
 
2.6 Assessment of mammalian cell viability by trypan blue method 
For counting cell suspensions, a mixture containing 10 µl of trypan blue (0.4% w/v) 
(Sigma), and 10 µl of the cell suspension was placed in a improved Neubauer (1/400 
mm
2 x 0.1 mm depth) counting chamber. After 10 min, the chamber was viewed by light 
microscopy and examined under 10 X objective lens. For each sample, the number of 
cells in 4 squares was determined, the average number of cells per single square was 
determined and multiplied by 2 x 10
4 to give the number of cells per ml. Viability of 
cells was determined by blue stained cells being counted as dead cells while clear cells 
were counted as viable. 
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2.7 Assessment of viability of J774.2 cells by MTT assay 
A colorimetric assay that determined the activity of mitochondrial dehydrogenases was 
the second method used to assess the viability of J774.2 cells. Live cells reduce [3-(4, 5-
dimethylthiazo-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma) by mitochondrial 
dehydrogenases to a purple formazan crystalline form in proportion to the number of 
viable cells. To 100 µl of cell culture in a well of a 96-well cell culture plate (Costar, 
3799), 50 µl of MTT at a final concentration of 1.5 mg/ml in RPMI 1640 (Gibco) 
without phenol red were then added. Cells were incubated for 40 min at 37ºC in the 5% 
CO2 atmosphere and then 50 µl of solubilization stop solution (0.5% w/v SDS, 25mM 
HCl in 90% v/v isopropanol) were added. Plates were incubated for 5 min on a rotating 
plate at 37ºC, each sample was mixed and the absorbance at 600nm was measured on a 
micro-plate reader (FLUO star OPTIMA, Germany). The % of dead cells was 
determined by: 
% Dead cells = 1- (OD (test)/ OD (-ve)) X 100 
test = cells treated with bacteria 
-ve = cells only. 
 
2.8 Adhesion and invasion assay  
2.8.1 J774.2 assay  
To determine if P. multocida strain B: 2 is able to invade mammalian cells and is 
capable of intracellular survival and growth, two cell types were used; J774.2 
macrophage-like cells and BL-3 bovine lymphoma cells. J774.2 macrophages cultured in 
RPMI complete medium were removed by scraping and were then washed with RPMI 
1640 basal medium by centrifugation at 1000 x g for 5 min and resuspended in RPMI 
  IVsupplemented with L-glutamine and foetal bovine serum (i.e. no antibiotics). Viable cell 
numbers were determined by trypan blue exclusion. Approximately 10
6 viable cells per 
ml were seeded into each well of a 6-well tissue culture plate. Actual numbers of viable 
cells were determined for each experiment. Macrophages were infected with 0.5 ml of a 
suspension of bacteria at 10
9 CFU/ml to give a multiplicity of infection (MOI) of 500:1 
and the plate incubated for 2 h at 37ºC, in 5% CO2, to allow bacterial adherence and/or 
invasion. In some experiments the 6-well plates were centrifuged at 1000 x g for 5 min 
to ensure close contact between the bacteria and mammalian cells. After incubation for 2 
h, the sample was centrifuged for 5 min at 1000 x g and the culture medium was 
discarded; the infected cells were carefully washed twice more by centrifugation at 1000 
x g for 5 min and resuspension in RPMI 1460 basal medium to remove extracellular 
bacteria and then resuspended in RPMI complete medium with gentamicin and 
polymyxin B sulphate, each at the final concentration of 350 µg/ml, to kill any 
remaining extracellular bacteria. Incubation was continued for 2 h. Cells were then 
washed 3 times as above with RPMI 1460 basal medium and lysed by addition of 
digitonin (Sigma) at a final concentration 100 µg/ ml for 30 min. The average number of 
viable intracellular bacteria was determined after plating 10-fold dilutions of the lysate 
in duplicate on BHI agar.  
 
2.8.2 BL-3 assay 
Cells were grown in complete BL-3 medium containing L-15 Leibovitz, RPMI 1640 
medium, L- glutamine, fetal bovine serum and penicillin, streptomycin solution. For the 
infection assay, the BL-3 cells were washed three times with fresh BL-3 medium to 
remove antibiotics and then resuspended in 5 ml of BL-3 medium. Approximately 10
6 
cells per ml were then infected with bacteria at a MOI 500:1 and the same procedure 
  Vused as for J774.2 cells was followed, except that BL-3 medium was used in place of 
RPMI (Section 2.8.1). The average number of viable intracellular bacteria was 
determined after plating 10-fold dilutions of the lysate in duplicate on BHI agar.  
 
2.9 Transmission electron microscopy  
Cell samples were fixed with 2.5 % (v/v) glutaraldehyde in 0.1 M PO4 buffer pH 7.4 for 
1 h, then rinsed 3 times with buffer containing 2% (w/v) sucrose for 5 min and stored in 
this solution at 4ºC overnight. Samples were then fixed with 1% (w/v) osmium tetroxide 
for 1 h at room temperature and rinsed 3 times for 20 min each with distilled H2O. An 
ethanol series containing 30%, 50%, 70%, 90% (v/v) ethanol was then applied for 10 
min each, followed by three changes at 100% ethanol for 10 min. Once sufficiently 
dehydrated, 3 time washes with 1:1 propylene oxide and resin were conducted overnight 
at room temperature on a rotator in a fume hood. The pellet was then embedded in fresh 
resin plus accelerator in a mould and resin polymerised at 60ºC for 48 h. Finally, 70-80 
nm sections were cut and stained with 2% (w/v) methanolic uranyl acetate and Reynolds 
lead citrate stain for 5 min. Sections were examined with a LEO 912AB transmission 
electron microscope operating at 80 KV, 1000x magnification.  
 
2.10 Statistical evaluation 
The results were assessed statically by student's t-test.   
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CHAPTER 3 
Results: 
 
3.1 Growth curves 
    The growth curves of P. multocida B:2 strains 85020 wild type and JRMT12 are 
shown in Figure 3. Both strains grew equally well in BHI medium. 
 
 
 
 
  
 
 
Figure 3: 
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Figure 3. Growth curves of P. multocida B: 2 strains. 
25 ml of BHIB was inoculated with 0.5 ml of overnight cultures of the strains 85020 and 
JRMT12 and incubated at 37°C with shaking. The OD at 600 nm was measured at 
intervals. 
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3.2 Rate of bacterial killing by antibiotics  
    Strains 85020 and JRMT12 were grown for 4 h in BHIB with shaking at 37°C to give 
log phase bacteria. Then, 10
5 CFU/ml were transferred to RPMI supplemented with the 
antimicrobials gentamicin and polymyxin B sulphate, separately or together, at 350 
µg/ml final concentration at 37ºC with shaking. At 0, 60 and 120 min, samples were 
removed for dilution and plating onto BHIA. According to the data in Table 3 (A and B), 
viability of the P. multocida B:2 strains decreased rapidly with both gentamicin and 
polymyxin used singly or together. Gentamicin and polymyxin together resulted in 
significantly reduced numbers of viable bacteria in comparison to each antibiotic used 
singly. In all cases, complete loss of CFU was observed only at 120 min, when no 
colonies of bacteria were detected. Thus, for both P. multocida B:2 85020 and JRMT12, 
a 120 min incubation period with both antibiotics was considered necessary to ensure 
elimination of all extracellular bacteria. It can be concluded that gentamicin and 
polymyxin exhibited bactericidal activity against P. multocida B:2 and, over 120 min, 
produced >99.9% killing of both strains if both antibiotics were used together.  
3.3 Mammalian cell viability  
3.3.1 Assessment of mammalian cell viability by trypan blue method   
    To examine the effect of P. multocida on viability of J774.2 cells, the cells were 
scraped from the tissue culture plates at 0, 2 and 4 h post-infection with bacteria at a 
MOI of 500:1 and resuspended in pre-warmed RPMI complete medium (without 
antibiotics) and cell viability was determined by trypan blue staining. Macrophage 
viability in the presence of P. multocida B:2 was compared to the control where no 
bacteria were present throughout the experiment. There were approximately 14% dead 
cells at 0 time in all three samples (Figure 4, A, B, C). At 2 h and 4 h, the percentage of  
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Table 3: Effect of antibiotics on the viable counts of the two strains of P. multocida 
B:2. Bacteria were diluted to 10
5 CFU/ml in RPMI medium containing a final 
concentration of 350 µg/ml each of gentamicin or polymyxin, alone or in combination. 
Cells were incubated at 37ºC and, at 0, 60, and 120 min, viable P. multocida B:2 were 
enumerated by plating 100 µl samples onto BHIA in triplicate and incubation at 37ºC 
overnight. 
A: Viable counts of P.multocida wild type 85020.  
B: Viable counts of P. multocida aroA JRMT12 
A:  
Time 
(min) 
measure 
Polymyxin (350µg/ml) 
 
CFU/100 µl at Dilution:  
Gentamicin (350µg/ml) 
 
CFU/100 µl at Dilution: 
Polymyxin and Gentamicin 
(350µg/ml of each) 
CFU/100 µl at Dilution: 
  Neat  10
-1 10
-2 Neat  10
-1 10
-2 Neat  10
-1 10
-2
0 ND  ~1950 210  ND  ~1900 210  ND  ~1800 220 
60 100  0  ND  70  0 ND  9 0 ND 
120 0  0 ND  0  0  ND  0  0  ND 
 
 
B:   
Time 
(min) 
measure 
Polymyxin (350µg/ml) 
 
CFU/100 µl at Dilution:  
Gentamicin (350µg/ml) 
 
CFU/100 µl at Dilution: 
Polymyxin and Gentamicin 
(350µg/ml of each) 
CFU/100 µl at Dilution: 
  Neat  10
-1 10
-2 Neat  10
-1 10
-2 Neat  10
-1 10
-2
0 ND  ~2600 290  ND  ~2500 300  ND  ~1900 210 
60 60  0  ND  120  0 ND  10  0 ND 
120 0  0 ND  0  0  ND  0  0  ND 
 
ND:   not done  
0 :  no colony detected  
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Figure 4: Assessment of viability of J774.2 cells by trypan blue method. Approximately 
10
6 cells were infected with log-phase P. multocida B:2 strains in RPMI complete 
medium (without antibiotics) at a ratio of 500:1 bacteria: J774.2 cell. The cells were 
centrifuged in 1000 x g for 5 min and incubated in 5% CO2 at 37ºC. The numbers of 
viable J774.2 cells were estimated at 0, 2 and 4 h by using trypan blue exclusion.    
 
A. Percentages of live and dead J774.2 cells in uninfected controls (average of 2 
determinations).  
B.  Percentage of live and dead J774.2 cells with wild-type P. multocida B:2 strain 
85020 (average of 2 determinations).  
C.  Percentage of live and dead J774.2 cells with the aroA derivative of P. multocida 
B:2 strain JRMT12 (average of 2 determinations).  
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  XI % Live Cells   % Dead Cells3.3 Mammalian cell viability  
3.3.1 Assessment of mammalian cell viability by trypan blue method   
    To examine the effect of P. multocida on viability of J774.2 cells, the cells were 
scraped from the tissue culture plates at 0, 2 and 4 h post-infection with bacteria at a 
MOI of 500:1 and resuspended in pre-warmed RPMI complete medium (without 
antibiotics) and cell viability was determined by trypan blue staining. Macrophage 
viability in the presence of P. multocida B:2 was compared to the control where no 
bacteria were present throughout the experiment. There were approximately 14% dead 
cells at 0 time in all three samples (Figure 4, A, B, C). At 2 h and 4 h, the percentage of  
dead cells had increased slightly in the untreated control (Figure 4 A). However, there 
were no significant differences in the number of dead cells in cultures with either strain 
of  P. multocida B:2 compared to the uninfected control (Figure 4, B, C), although 
incubation in the presence of the two P. multocida B:2 strains reduced the percentage 
viability of J774.2 cells to values that were slightly lower than the control values at 2 h 
for both strains. The loss in viability was more apparent with the wild-type 85020 at 4 h 
than with JRMT12 (Figure 4 B and C). This small difference may have been due to 
variations in the experimental procedure and may not have been significant. Overall our 
data showed a slight decrease in viability of J774.2 in presence of bacteria when 
compared to the control, suggesting that P. multocida B:2 had some slight toxicity to 
host cells. However, when the viability of BL-3 cells was determined with the same 
assay, the cells were not damaged by exposure to P. multocida B:2 (Figure 5). In this 
experiment, fewer dead cells were observed for the BL-3 cells compared to the J774.2  
cells, and there were no significant differences in cell viability in the presence of either 
strain of P. multocida B:2 compared to the control.  
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Figure 5: Assessment of viability of BL-3 cells by trypan blue method. Approximately 
10
6 cells were infected with log-phase P. multocida B:2 strains in BL-3 medium free of 
antibiotics at a ratio of 500:1 bacteria: BL-3 cell.  The cells were centrifuged in 1000 x-g 
for 5 min and incubated in 5% CO2 at 37ºC. The numbers of viable cells were estimated 
at 0, 2 and 4 h by using trypan blue exclusion.    
 
A. Percentages of live and dead BL-3 cells in uninfected controls (average of 2 
determinations).  
B.  Percentages of live and dead BL-3 cells with wild-type P. multocida B:2 strain 
85020 (average of 2 determinations).  
C.  Percentages of live and dead BL-3 cells with the aroA derivative of P. multocida 
B:2 strain JRMT12 (average of 2 determinations). 
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  XIV3.3.2 Assessment of changes in the J774.2 cell viability by MTT assay 
    The data above suggested P. multocida B:2 failed to kill J774.2 or BL-3 cells. A 
colorimetric assay that determines the activity of mitochondrial dehydrogenases was the 
second method used to assess the viability of J774.2 cells exposed to P. multocida B:2 
strains and other bacteria. Approximately 10
6 J774.2 cells were resuspended with RPMI 
complete medium (without antibiotics) without phenol red in 6-well cell culture plates 
and mixed bacteria at ratio of 500:1 bacteria: J774.2 cells. Samples were then 
centrifuged at 1000 x g for 5 min at room temperature. Following an invasion incubation 
period of 2 h, 100 µl of mixture transferred to a 96-well cell culture plate and 50 µl of 
MTT dye at a concentration of 1.5 mg/ml in RPMI without phenol red were added, cells 
were incubated for 40 min at 37ºC at 5 % CO2. Without washing or removing the 
supernatant, 50 µl of solubilization stop solution were added to dissolve the purple 
formazan product to give a coloured solution. After 5 min incubation, plates were read at 
a wavelength 600 nm with any automated micro-plate reader that determines the extent 
of reduction MTT. The result indicated that, in general, greater values were obtained at 4 
h than at 2 h, which would perhaps be expected with a greater period of metabolic 
activity. However, the reduction of MTT was higher for cells that harboured bacteria, 
due presumably to the activity of to bacterial dehydrogenises (Table 4 A and B). This 
was reflected in the high values obtained after incubation of MTT with bacteria alone. 
Any loss of viability of J774.2 cells upon exposure to the bacteria was, therefore, being 
masked by the bacterial activity. This assay was not therefore considered suitable for 
assessing mammalian cell viability in presence of live bacteria. 
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Table 4: Total effect of bacteria on the J774.2 cells by MTT assay. Approximately 10
6 
cells were infected with P. multocida B:2 strains, P. multocida A:3 and E. coli XL1-Blue 
at a ratio 500:1 bacteria to J774.2 cells. After 2 h incubation, 100 µl of infected cells 
transferred to the 96- well plate. 50 µl of MTT at a final concentration 1.5 mg/ml were 
added and cells were incubated for 40 min. cells were then treated with 50 µl stop 
solution and left for 5 min. sample were then read at 600 nm wave length.  
 
A. The average of 4 determination absorbance of infected J774.2 cells with or 
without bacteria after 2 h incubation. 
B. The average of 4 determination absorbance of infected J774.2 cells with or 
without bacteria after 4 h incubation. 
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A:  
Cell treatments  Average absorbance at 
600 nm  
J774.2 cells without treatment (-ve 
control) 
0.57 
J774.2 cells with Triton X-100 (+ve 
control, 100% killing) 
0.16 
P.m 85020 +J774.2 cells   2.47 
P.m JRMT12+J774.2 cells   2.15 
P.m A:3+J774.2 cells   2.8 
E. coli +J774.2 cells   1.9 
P.m 85020 alone   1.7 
P.m JRMT12 alone  1.35 
P.m A:3   alone  1.7 
E. coli   alone  1.3 
MTT alone   0.1 
 
P. m 85020: P. multocida B:2 strain 85020 
P. m JRMT12: P. multocida B:2 strain JRMT12 
P. m A:3 : P. multocida A:3  
E. coli : E. coli XL1-Blue  
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B:  
Cell treatments  Average absorbance at 
600 nm  
J774.2 cells without treatment (-ve 
control) 
1.0 
J774.2 cells with Triton X-100 (+ve 
control, 100% killing) 
0.18 
P.m 85020 +J774.2 cells   1.25 
P.m JRMT12+J774.2 cells   1.75 
P.m A:3+J774.2 cells   1.8 
E. coli +J774.2 cells   1.9 
P.m 85020 alone   1.1 
P.m JRMT12 alone  1.04 
P.m A:3   alone  0.79 
E. coli   alone  2.0 
MTT alone   0.19 
 
P. m 85020: P. multocida B:2 strain 85020 
P. m JRMT12: P. multocida B:2 strain JRMT12 
P. m A:3 : P. multocida A:3  
E. coli : E. coli XL1-Blue  
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3.4 Uptake and intracellular survival of bacteria 
3.4.1 J774.2 Assay  
    Intracellular detection of the parent 85020 strain and the JRMT12 aroA P. multocida 
B:2 strain within cultured macrophage-like cells was determined by infecting J774.2 
cells with P. multocida strains at a ratio of 500: 1 bacteria: J774.2 cell. In some 
experiments, the effect of close cell-to-cell contact was examined by centrifugation of 
the tissue culture plate in order to directly deposit the bacteria onto the macrophages 
(Table 5 Exp. 1A, 1B, 2A, 2B, Table 6 Exp. 1B, 2B, 3A, 3B, Table 7 Exp. 1, 2, Table 8 
Exp. 1). After exposure of the bacteria to the macrophages for 2 h, washing was done to 
remove the majority of extracellular bacteria and then residual extracellular bacteria 
were killed with a combination of gentamicin and polymyxin B sulphate for 2 h (Table 5 
Exp. 1A, 2A, Table 6 Exp 1A, 1B, 2A, 2B, 3A, 3B, Table 7 Exp. 1A, 1B, 2A and Table 
8 Exp. 1A, 1B, 1C). In some assays, the antibiotics were omitted in order to measure 
both adherence and invasion (Table 5 Exp.1B, 2B, Table 6 Exp. 1B, 2B, 3B, 3D and 
Table 7 Exp 2B, 2D, 2F). A further 3 washes to remove antibiotics was followed by 
exposure to digitonin for 30 min at a final concentration of 100 µg/ml to lyse the 
mammalian cells and release intracellular bacteria. Serial 10-fold dilutions were 
prepared from each sample in PBS and 100 µl portions spread on BHI agar and 
incubated at 37°C for 48 h. The viable count results are shown in Tables 5, 6, 7 and 8. 
 
    We first compared the number of intracellular bacteria after treating J774.2 cells with 
bacteria without centrifugation and with and without treatment with antibiotics. Bacterial 
counts made after treatment with and in the absence of antibiotics would represent 
intracellular and adherent plus intracellular bacteria, respectively (Table 5 Exp. 1A and 
  XIX1B). The counts from the 10
-2 dilution were used to calculate intracellular bacteria and 
10
-3 dilution to calculate adherent bacteria per cell. The average number of intracellular 
wild-type 85020 strain was determined to be ~0.03 per J774.2 cell while 0.22 bacteria 
per J774.2 cell were detected without antibiotics, indicating a combination of binding 
and invasion. For the JRMT12 strain under the same conditions, an intracellular count of 
~0.09 bacteria/ cell was detected with 0.41 bacteria/ cell without antibiotics (Table 5 
Exp1A, 1B and 2A, 2B). There was an indication, therefore; that following infection of 
macrophage cells for 2 h, strain 85020 showed a slightly lower invasive capacity 
compared with strain JRMT12 which may have been a reflection of greater adherence by 
JRMT12. Similar results were obtained when a centrifugation step was included: fewer 
invasive bacteria were detected with the wild-type strain compared with JRMT12 strain 
(0.19 versus 0.31 bacteria/ cell) (Table 6 Exp 1, 2). When invasion capacity was 
compared when cells and bacteria were centrifuged together and those not, a clear 
increase in intracellular bacteria was obtained after centrifugation (Table 6 Exp 1A and 
2A, compared with Table 5 Exp 1A and 2A). The centrifugation assay also increased the 
numbers of bacteria judged to be adherent or intracellular, to 3.45 and 5.6 bacteria cell 
with strain 85020 and strain JRMT12, respectively with (Table 6 Exp. 1B and 2B). 
These data indicated that a greater number of bacteria were able to adhere to and invade 
cells after centrifugation.  
 
    As expected, if antibiotics were maintained in the culture medium and cells were then 
exposured to digitonin, no bacterial colonies were detected, presumably because the 
suspending medium would rapidly kill them (Table 6, Exp. 3A, 3C).  
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Table 5: Adhesion and intracellular survival of P. multocida B:2 strains with J774.2 
macrophage-like cells. J774.2 cells and P. multocida were mixed at a MOI of 1:500, left 
2 h and, after removal of most of the extracellular bacteria by centrifugation and 
washing, either the J774.2 cells were treated with antibiotics (gentamicin and 
polymyxin, each at 350µg/ml final concentration) or left untreated for 2 h. After further 
centrifugation and washing, J774.2 cells were lysed with digitonin and viable bacteria 
recovered after dilution and plating (see section 2.7.1). The number of intracellular 
bacteria was calculated using the counts from the 10
-2 dilution and numbers of adherent 
bacteria using the 10
-3 dilution (see section 2.8.1).  
 
 
 
 
 
 
 
 
 
 
  XXIExperiment 1 
 
A. P.m 85020 + J774.2 cells:    No centrifugation,   left 2h,   2x wash,   antibiotics added,   left 2h,   3x wash,   digitonin added, left 30 min,   
plate out  
B. P.m 85020 + J774.2 cells:               ``                     ``              ``            no antibiotics            ``              ``                     ``                  ``                 ` 
  Treatments   CFU/ 100 µl at dilution 
          10
-2                   10
-3               10
-4        10
-5
Number of intracellular 
bacteria/J774.2 cell 
Number of intracellular + 
adherent bacteria / J774.2 cell 
A  P.m 85020+ cells   440  0      ~ 0.03   
B  ``            ``               ``  2640  342  0      0.22 
 
Experiment 2 
 
A. P.m JRMT12+ J774.2 cells:    No centrifugation,  left 2h,   2x wash,   antibiotics added,   left 2h,  3x wash,   digitonin added,  left 30 min,  
plate out  
B. P.m JRMT12+ J774.2 cells:              ``                        ``             ``            no antibiotics          ``             ``                   ``                  ``               ``    
  Treatment  CFU/ 100 µl at dilution 
          10
-2                   10
-3                10
-4            10
-5
Number of intracellular 
bacteria/J774.2 cell 
Number of intracellular + 
adherent bacteria / J774.2 cell 
A  P.m JRMT 12 + cells   650  3  0    ~ 0.09   
B  ``            ``                ``  1620  310  0      0.413 
 
 
  ITable 6: Adhesion and intracellular survival of P. multocida B:2 strains with J774.2 
macrophage-like cells. J774.2 cells and P. multocida were mixed at a MOI of 1:500, and 
centrifuged at 1000 x g for 5 min (Exp. 1 and 2) or left non-centrifuged (Exp. 3). Cells 
were then incubated for 2 h followed by removal of most of the extracellular bacteria by 
centrifugation and washing. The J774.2 cells were treated with antibiotics (gentamicin 
and polymyxin, each at 350µg/ml final concentration) or left untreated for 2 h. After 
further centrifugation and washing (Exp. 1 and 2), J774.2 cells were lysed with digitonin 
and viable bacteria recovered after dilution and plating (see section 2.7.1). In Exp. 3, no 
washes step to remove antibiotics was done. The number of intracellular bacteria was 
calculated using the counts from the 10
-3 dilution and numbers of adherent bacteria using 
the 10
-5 dilution. The numbers of adherent bacteria for Exp. 3B and 3D were calculated 
using the 10
-4 dilution (see section 2.8.1).  
  IExperiment 1 
 
A. P.m 85020 + J774.2 cells:  Centrifugation,  left 2h,  2x wash,  antibiotics added,   left 2h,   3x wash,   digitonin added,  left 30 min,  plate out  
B. P.m 85020 + J774.2 cells:            ``                    ``             ``         no antibiotics            ``             ``                   ``                  ``               ``    
 
  Treatment   CFU/ 100 µl at dilution 
           10
-2                   10
-3                      10
-4                10
-5
Number of intracellular 
bacteria/J774.2 cell 
Number of intracellular + 
adherent bacteria / J774.2 cell 
A  P.m 85020+ cells  1860  210  0  0  0.19   
B  ``             ``              ``  NC  3850  410  38    3.45 
 
 
Expriment 2 
 
A. P.m JRMT12+ J774.2 cells:   Centrifugation,   left 2h,   2x wash,   antibiotics added,   left 2h,   3x wash,   digitonin added, left 30 min  plate 
out  
B. P.m JRMT12+ J774.2 cells:            ``                    ``             ``            no antibiotics        ``             ``                    ``              ``                ``    
 
  Treatment   CFU/ 100 µl at dilution 
           10
-2                  10
-3                     10
-4                 10
-5
Number of intracellular 
bacteria/J774.2 cell 
Number of intracellular + 
adherent bacteria / J774.2 cell 
A                P.m  JRMT  12+cells 1610 341 31 0 0.31
B  ``             ``              ``  NC  4400  630  56    5.6 
 
NC non countable. 
  I 
 
  IExperiment 3 
 
A. P.m 85020 + J774.2 cells:   No centrifugation,  left 2h,   2x wash,  antibiotics added,   left 2h,   no wash,   digitonin added, left 30 min,   plate 
out 
B. P.m 85020 + J774.2 cells:                 ``                  ``                ``         no antibiotics            ``             ``                    ``                   ``                      
`` 
C. P.m JRMT12+ J774.2 cells:             ``                   ``                ``        antibiotics added         ``               ``                   ``                    ``                
``   
D. P.m JRMT12+ J774.2 cells:              ``                   ``               ``         no antibiotics              ``                 ``                    ``                 ``             ``      
  Treatments   CFU/ 100 µl at dilution 
           10
-1                   10
-2                     10
-3               10
-4
Number of intracellular 
bacteria/J774.2 cell 
Number of intracellular + 
adherent bacteria / J774.2 cell 
A  P.m 85020 + cells   0  0      0   
B  ``            ``                ``    NC  NC  719  58    1.36 
C  P.m JRMT12+ cells  0  0      0   
D  ``            ``                ``      NC  NC  1815  118    2.8 
 
NC non countable 
  IWhen no antibiotics were employed together with no washing after 2 h (Table 6, Exp. 
3A, 3D), the number of adherent bacteria higher than when washing was included (Table 
5, Exp. 1B, 2B) which would indicate that the further washing step removed loosly 
attached bacteria. Table 7 summarises three further experiments to confirm the data on 
invasion of the parent 85020 and aroA strain JRMT12 with and without initial 
centrifugation. In two of the experiments, JRMT12 showed greater invasive capacity 
than 85020 (Table 7, Exp 1A compared to Exp 2A and Exp 3 compared to Exp. 3B), but 
in the other (Table 7, Exp 1B compared to Exp 2B) the reverse was true. Overall, the 
combined data did indicate that JRMT12 had a slightly better invasive capacity than the 
parent 85020 strains and perhaps the best comparison is Table 7, Exp. 3 where the two 
strains were compared during the same experiment.  
 
    Comparisons were made between the P. multocida B:2 strains and E. coli XL 1-Blue  
and P. multocida serogroup A:3 (Table 8 Exp. 1 and 2). The data in Table 8, experiment 
1, revealed that the 85020 serotype B:2 strain had a significantly higher (~100-fold ) 
capacity for  invasion than the P. multocida A:3 strain which was in turn 10-20 fold 
better than E. coli XL1-Blue, which exhibited a very low number of intracellular 
bacteria. Essentially, similar results were obtained in a repeat experiment (Table 8 Exp. 
2) where P. multocida B:2 JRMT12 was used instead of 85020. It should be noted that 
adhesion of the A:3 and E. coli XL1-Blue strains were ~ 50% of that of the P. multocida 
B:2 strains but this would only in part account for the much lower invasive capacity. In 
conclusion, the results indicated that both wild type strain 85020 and an aroA mutant 
strain JRMT12 could enter mammalian cells and survive for at least 2 h (Tables 5, 6, 7 
and 8). Without antibiotics, ~10-fold more bacteria were shown to be adherent to J774.2 
cells. The capacity of P. multocida A:3 and E. coli XL1- Blue to adhere to J774.2 cells 
  Iwas only slightly lower than that of P. multocida B:2 strains, but their invasive capacity 
was markedly less.  
 
3.4.1.1 Intracellular growth  
    To determine if intracellular growth and replication of internalised P. multocida B:2 
occurred within J774.2 cells, the cells were incubated for a further 2 h (total of 6 h) after 
the extracellular bacteria had been removed from the medium by treatment with 
antibiotics. After this extra period of time, more intracellular bacteria were recovered 
(Table 9, Exp. 1A) compared with the situation if this 2 h extension was not included 
(Table 9, Exp. 1B). However, if cells were incubated with fresh RPMI medium 
containing 50 µg/ml final concentration each of polymyxin and gentamicin for the extra 
2 h, considerably fewer intracellular bacteria were recovered (Table 9 Exp. 1C). These 
data might suggest that the apparent increase in the number of intracellular bacteria per 
J774.2 cell between 4 and 6 h resulted from increased growth of surviving extracellular 
bacteria rather than division of bacteria within the cells. However, it is also possible that 
this extended time period allowed the antibiotics to penetrate the J774.2 cells and start to 
kill the intracellular bacteria. 
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  ITable 7: Summary of three different experiments on intracellular survival of P. 
multocida B:2 strains with J774.2 macrophage-like cells. In some experiments, J774.2 
cells were centrifuged at 1000 x g for 5 min immediately after exposure to bacteria (Exp. 
1B, 2B, and 3A, 3B), while in others the centrifugation step was omitted (Exp. 1A and 
2A). Antibiotics (gentamicin and polymyxin, each at 350µg/ml final concentration) were 
added. Number of intracellular bacteria was calculated using the count from the 10
-3 
dilution except for Exp.3A where the 10
-2 dilution was used.  
  IExperiment 1 
 
A. P.m 85020 + J774.2 cells:    No centrifugation,    left 2h,   2x wash,   antibiotics added,   left 2h,   3x wash,   digitonin added,  left 30 min,  
plate out  
B. P.m 85020 + J774.2 cells:    Centrifugation           ``                    ``             ``                   ``                ``                ``                ``              `` 
  Treatments   CFU/ 100 µl
 at dilution 
          10
-2                    10
-3                        10
-4              10
-5
Number of intracellular 
bacteria/J774.2 cell 
Number of intracellular + 
adherent bacteria / J774.2 cell 
A  P.m 85020+ cells  1045  126  0  0  0.21   
B  P.m 85020+ cells  2460  371  0  0  0.64   
 
Experiment 2 
 
A. P.m JRMT12+ J774.2 cells:    No Centrifugation,   left 2h,   2x wash,    antibiotics added,   left 2h,    3x wash,   digitonin added,  left 30 min,  
plate out  
B. P.m JRMT12+ J774.2 cells:    Centrifugation            ``             ``                 ``                    ``              ``                ``                       ``                 `` 
 
  Treatments   CFU/ 100 µl at dilution  
          10
-2                    10
-3                       10
-4           10
-5
Number of intracellular 
bacteria/J774.2 cell 
Number of intracellular + 
adherent bacteria / J774.2 cell 
A  P.m JRMT 12+ cells  1106  224  0    0.28   
B  P.m JRMT 12+ cells  1214  252  0    0.315   
 
  IExperiment 3 
 
A. P.m 85020+ J774.2 cells:     Centrifugation   left 2h,   2x wash,   antibiotics added,   left 2h,    3x wash,   digitonin added,  left 30 min,   plate 
out  
B. P.m JRMT12+ J774.2 cells:          ``                    ``             ``                   ``                   ``             ``                    ``                    ``                  ``    
 
  Treatments   CFU/ 100 µl at dilution 
         10
-1                            10
-2                     10
-3                   10
-4
Number of intracellular 
bacteria/J774.2 cell  
Number of intracellular + 
adherent bacteria / J774.2 cell  
A  P. m 85020 + cells   NC  214  0  0  0.06   
B  P. m JRMT12 + cells   NC  570  128  0  0.178   
              
 
 
NC non countable 
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Table 8: Adhesion and intracellular survival of P. multocida B:2 strains compared to P. 
multocida serogroup A:3 and E. coli XL1-Blue with J774.2 macrophage-like cells. Cells 
were centrifuged at 1000 x g for 5 min immediately after exposure to bacteria. In some 
assays, antibiotics (gentamicin and polymyxin, each at 350µg/ml final concentration) 
were added (Exp. 1A, 1C, 1E and 2A, 2B, 2C), while in others (Exp. 1B, 1D, 1F), the 
antibiotic treatment was omitted. Number of intracellular bacteria were calculated using 
the counts from the 10
-3 dilution for Exp.1A and Exp. 2A, 2D, 2F and 10
-1 dilution for 
Exp. 1B, 1C and Exp 2C and 2F. The numbers of adherent bacteria were calculated 
using the 10
-4 dilution for Exp 2B and the 10
-3 dilution for Exp.2 A, 2D and 2F.  
  IExperiment 1 
 
A. P.m 85020 + J774.2 cells:  Centrifugation,   left 2h,   2x wash,   antibiotics added,   left 2h,  3x wash,  digitonin added,  left 30 min,   plate out  
B. P.m A:3 + J774.2 cells:               ``                      ``             ``                   ``                       ``             ``                       ``                   ``              ``    
C. E. coli  + J774.2 cells :                ``                       ``             ``                   ``                       ``             ``                      ``                     ``              ``    
 
  Treatments   CFU/ 100 µl at dilution 
           10
-1                            10
-2                   10
-3              10
-4
Number of intracellular 
bacteria/J774.2 cell  
Number of intracellular + 
adherent bacteria / J774.2 cell  
A  P. m 85020 + cells  NC  NC  128  0  0.2   
B  P. m A3 + cells   211  0      0.0034   
C  E. coli + cells  103  0      0.0016   
P. m  P. multocida   E. coli  Escherichia coli   P.m. A:3  P.multocida A:3  NC non countable 
 
 
 
 
 
 
 
 
  IExperiment 2 
 
A. P.m JRMT12 + J774.2 cells:  Centrifuged,  left 2h,   2x wash,   antibiotics added,   left 2h,   3x wash,   digitonin added,  left 30 min,   plate out  
B. P.m JRMT12 + J774.2 cells:          ``               ``           ``             no antibiotics            ``             ``               ``            ``                  ``         `` 
C. P.m A:3 + J774.2 cells:              ``                ``            ``          antibiotics add              ``             ``                ``            ``                 ``         `` 
D. P.m A:3 + J774.2 cells:                 ``                 ``            ``           no antibiotics               ``              ``               ``            ``                 ``          `` 
E. E. coli  + J774.2 cells:                   ``                 ``             ``         antibiotics add               ``              ``               ``             ``                ``          `` 
F. E. coli  + J774.2 cells:                   ``                  ``            ``           no antibiotics                 ``             ``               ``             ``                ``          `` 
 
  Treatments   CFU/ 100 µl at dilution 
          10
-1                    10
-2                     10
-3              10
-4
Number of intracellular 
bacteria/J774.2 cell  
Number of intracellular + 
adherent bacteria / J774.2 cell  
A  P. m JRMT12 + cells NC  NC  108    0.24   
B  P. m JRMT12 + cells NC  NC  NC  116    2.57 
C  P. m A3 + cells   480  0      0.01   
D  P. m A3 + cells   NC  NC  418  0    1.6 
E  E. coli + cells  83  0      0.00014   
F  E. coli + cells  NC  NC  614  0    1.36 
 
P. m  P. multocida   E. coli  Escherichia coli   P.m. A:3  P.multocida A:3  NC non countable 
 
 
  IITable 9: Intracellular survival of P. multocida B:2 85020 strains within J774.2 
macrophage-like cells. Cells were centrifuged at 1000 x g for 5 min immediately after 
exposure to bacteria. Antibiotics (gentamicin and polymyxin, each at 350µg/ml final 
concentration) were added for 2 h. Cells were then washed 3 times to remove the 
antibiotics and then incubated for 2 h (Exp. 1A) before digitonin treatment or the cells 
were treated directly with digitonin (Exp. 1B) or antibiotics (gentamicin and polymyxin, 
each at 50µg/ml final concentration) were added with a further incubation for 2 h before 
treatment with digitonin (Exp. 1C). The number of intracellular bacteria for Exp. 1A was 
calculated using the counts from the 10
-3 dilution and in Exp. 1A and 1B from the 10
-2 
dilution. 
 
  IExperiment 1 
 
A. P.m 85020 + J774.2 cells:  Centrifugation,    left 2h ,  2x wash,  antibiotics added,  left 2h,   3x wash,  left 2h,  digitonin added, left 30 min,  plate out 
B. P.m 85020 + J774.2 cells:       ``         ``            ``               antibiotics added      ``              ``       digitonin added,    left 30 min           ``  
  C. P.m 85020 + J774.2 cells:      ``            ``              ``                       ``                     ``              ``       antibiotics added 50µg/ml, left 2h,   digitonin added, left 30 
min  Plate out 
  Treatments   CFU/ 100 µl at dilution 
          10
-1                     10
-2               10
-3        10
-4
Number of intracellular 
bacteria/J774.2 cell  
Number of intracellular + 
adherent bacteria / J774.2 cell  
A  P. m 85020 + cells  NC  NC  101    1.629   
B  P. m 85020 + cells   NC  415  0    0.092   
C  P. m 85020 + cells  778  198  0    0.04   
 
NC non countable           
 
 
 
 
 
 
  I3.4.2 BL-3 cell assay  
    P. multocida B:2 strains were also tested for their ability to invade and survive in BL-
3 cell cultures. After an infection period of 2 h, the BL-3 cells were washed and 
resuspended in fresh BL-3 medium with polymyxin and gentamicin each at a final 
concentration of 350 µg/ml, to kill extracellular bacteria. As in the experiment with the 
J774.2 cells, viable intracellular bacteria of both strains were recovered from lysed cells 
to quantify the invasion ability by counting of intracellular CFU/ml on BHI agar. The 
data in Table 10 (Exp. 1 and 2) showed that the JRMT12 strain was able to invade cells 
slightly better than the parent strain 85020, as was seen with J774.2 cells. However, the 
invasive capacity of the P. multocida B:2 strains for BL-3 cells was less than that for 
J774.2 cells (section 3.3.1, Tables 5, 6, 7 and 8) even when initial centrifugation was 
employed to encourage contact between cells.  
 
    Again,  the  invasive  capacity  of  P. multocida A:3 and E. coli XL1-Blue were 
compared with the P. multocida B:2 strains (Table 11, Exp. 1 and 2). As noted for 
J774.2 cells (Table 8), the invasive capacity of the P. multocida A:3 and E. coli XL1-
Blue were markedly poorer than both 85020 and JRMT12 P. multocida B:2 strains. As 
with J774.2 cells, the numbers of bacteria judged to be adherent and or invasive was 
similar for all three strains (Table 11, Exp. 1). Thus, as with the J774.2 cells, the B:2 
strains showed ~ 100 –fold greater invasive capacity for BL-3 cells than the A:3 and E. 
coli XL1-Blue strains, even though all three strains showed a similar attachment 
capacity. However, the invasive capacity of the P. multocida B:2 strains for BL-3 cells 
was ~5-fold less efficient than with J774.2 cells. 
 
 
  ITable 10: Adhesion and intracellular survival of P. multocida B:2 strains with BL-3 
cells. Bacteria were mixed with BL-3 cells at a MOI of 500:1 and centrifuged at 1000 x 
g for 5 min immediately after exposure of BL-3 cells to the bacteria. In some assays, 
antibiotics (gentamicin and polymyxin, each at 350 µg/ml final concentration) were 
added (Exp. 1A and 2A), while in others (Exp. 1B and 2B), the antibiotic treatment was 
omitted. The number of intracellular bacteria was calculated using the counts from the 
10
-2 dilution and numbers of adherent bacteria using the 10
-3 dilution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  IExperiment 1  
 
A. P.m 85020 + BL-3 cells:   Centrifugation,   left 2h,   2x wash,   antibiotics added,   left 2h,   3x wash,  digitonin added, left 30 min,  plate out  
B. P.m 85020 + BL-3 cells:         ``                 ``             ``              no antibiotics         ``             ``                    ``              ``               ``    
  Treatments   CFU/ 100 µml at dilution 
         Neat                   10
-1                    10
-2                 10
-3
Number of intracellular 
bacteria/BL-3 cell 
Number of intracellular + 
adherent bacteria / BL-3 cell 
A                P.m.  85020  +cells NC 2840 216 0 0.045
B                P.m.  85020  +cells NC N.C N.C 401 0.84
 
Experiment 2  
 
A. P.m JRMT12+ BL-3 cells:  Centrifugation,  left 2h,   2x wash,   antibiotics added,  left 2h,   3x wash,  digitonin added,  left 30 min,  plate out  
B. P.m JRMT12+ BL-3 cells:          ``                    ``             ``            no antibiotics          ``             ``                   ``                   ``                  ``    
  Treatments   CFU/ 100 µl at dilution 
         Neat                   10
-1                      10
-2            10
-3
Number of intracellular 
bacteria/BL-3 cell 
Number of intracellular + 
adherent bacteria / BL-3 cell 
A  P.m. JRMT12 +cells  N.C  N.C  416  0  0.067   
B  P.m. JRMT12 +cells  NC  N.C  2428  303    0.48 
 
NC: non countable   
  I 
Table 11: Adhesion and intracellular survival of P. multocida B:2 strains, P. multocida 
serogroup A:3 and E. coli XL1-Blue with BL-3 cells. Cells were centrifuged at 1000 x g 
for 5 min immediately after exposure to bacteria. In some assays, antibiotics (gentamicin 
and polymyxin, each at 350 µg/ml final concentration) were added (Exp. 1A, 1C, 1E and 
2A, 2B, 2C), while in others (Exp. 1B, 1D, 1F), the antibiotic treatment was omitted. 
The number of intracellular bacteria were calculated using the counts from the 10
-2 
dilution Exp.1A and 10
-1 dilution for Exp. 1C and 1E. The numbers of adherent bacteria 
were calculated from the 10
-3 dilution, apart from Exp. 1F where the 10
4 dilution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  IExperiment 1 
 
A. P.m JRMT12 + BL-3 cells:  Centrifugation,  left 2h,   2x wash,  antibiotics added,  left 2h,  3x wash,  digitonin added,  left 30 min plate out  
B. P.m JRMT12 + BL-3 cells:         ``              ``         ``      no antibiotics         ``             ``               ``            ``                  ``  
C. P.m A:3 + BL-3 cells:                   ``                 ``         ``          antibiotics added           ``             ``                ``            ``                 `` 
D. P.m A:3 + BL-3 cells:         ``                 ``         ``           no antibiotics            ``              ``               ``            ``                 `` 
E. E. coli  + BL-3 cells:                           ``                   ``         ``         antibiotics added           ``              ``               ``             ``                `` 
F. E. coli  + BL-3 cells:                           ``                    ``        ``           no antibiotics            ``             ``               ``             ``                `` 
 
  Treatments   CFU/ 100 µl at dilution 
          10
-1                     10
-2                     10
-3             10
-4
Number of intracellular 
bacteria/J774.2 cell  
Number of intracellular + 
adherent bacteria / J774.2 cell  
A  P. m JRMT12 + cells NC  314  0    0.066   
B  P. m JRMT12 + cells NC  NC  467  0    0.3 
C  P. m A3 + cells   117  0      0.0023   
D  P. m A3 + cells   NC  NC  651  0    0.39 
E  E. coli + cells  11  0      0.0002   
F  E. coli + cells  NC  NC  NC  43    0.686 
P. m  P. multocida   E. coli  Escherichia coli   P.m. A:3  P.multocida A:3  NC non countable 
 
  I 
3.5 Electron microscopy 
        To study further the fate of intracellular bacteria, TEM studies were performed 
(Figures 6 and 7). J774.2 macrophage cells and BL-3 cells were treated with P. 
multocida serogroup B:2 strain 85020, P. multocida serogroup A:3 and E. coli XL1-
Blue. Cells were infected at a MOI of 500:1 in 6-well tissue culture plates. Fixation of 
samples was done with glutaraldehyde and osmium tetroxide after an incubation period 
of 4 h (Figures 6 A-F, and 7 A-F) and 6 h (Figures 6 G-L, and 7 G-L). After dehydration 
via graded alcoholic steps, the samples were embedded in epon and serial ultra thin 
sections were stained with uranyl acetate and lead citrate before examination with the 
LEO 912AB transmission electron microscope. 
 
3.5.1 J774.2 cell micrography 
    With the P. multocida B:2 85020 strain, J774.2 cells with intracellular bacteria were 
observed (Figures 6 A, C, H) but extracellular bacteria were also seen in close 
association with the plasma membrane (Figure 6 H). Intracellular bacteria were not seen 
with P. multocida A:3 and E. coli XL1-Blue, although J774.2 cells showed cytoplasmic 
extensions around the bacteria which could be interpreted as being the first step in the 
engulfment process (Figures 6 E and K). An assessment of the morphological features 
seen by TEM after infection of J774.2 cells with P. multocida B:2, P. multocida A:3 and 
E.coli XL1-Blue is summarized in Table 12. Vacuolation was observed at both 4 h or 6 
h postinfection (Figures 6 B, C, G and I), with P. multocida B:2, and approximately 10% 
of the J774.2 cells showed this feature at 4 h (Table 12A). The intracellular bacteria 
(seen in 28% of cells examined, Table 12A) were generally situated within membrane-
bound vacuoles (Figures 6 A, C, H), although occasionally a bacterium free in the  
  IFigure 6: TEM of J774.2 cells infected with bacteria. J774.2 cells were infected at a 
MOI of 500:1 with P. multocida B:2 strains 85020, P. multocida serogroup A:3 or E.coli 
XL1-Blue. Cells were  centrifuged at 1000 x g for 5 min and incubated for 2 h. Removal 
of most extracellular bacteria by centrifugation and washing was then performed. The 
J774.2  cells were treated with antibiotics (gentamicin and polymyxin, each at 350 µg/ml 
final concentration) for 2 h, then antibiotics were removed by washing and samples 
taken for TEM at 4 h (A-F),or 6 h (G-L). The main features to note are cytoplasmic 
vacuoles and localization of intracellular bacteria. Non-internalised bacteria were also 
detected.  
A- P. multocida B:2 (arrowed) within phagosomes (4 h incubation). 
B-   J774.2 cell treated with P. multocida B:2. A number of vacuoles are visible (4 h 
incubation).  
C- Vacuoles and a P. multocida B:2 cell within a phagosome  (arrow 1) and a 
bacterial cell free within the cytoplasm (arrow 2) (4 h incubation).  
D- Normal appearance of a J774.2 cell without bacteria (4 h incubation). 
E-  P. multocida A:3 cells associated with the extended (arrowed) surface of a 
J774.2 cell  (4 h incubation). 
F-  A J774.2 cell after incubation with E. coli XL-Blue (4 h incubation). 
G-  Vacuolation of a J774.2 cell treated with P. multocida B:2 strain (6 h 
incubation). 
H- Intracellular P. multocida B:2 cells within a J774.2 cell  and associated with the 
extended cell membrane (arrowed).  (6 h incubation).  
I- Damaged J774.2 cell after treatment with P. multocida B : 2  s t r a i n  ( 6  h  
incubation). 
J-  Untreated J774.2 cell (6 h incubation). 
K- A J774.2 cell treated with P. multocida A:3 (6 h incubation), showing extended 
membrane projections  (arrowed). 
L-  A J774.2 cell after incubation with E. coli strain XL1-Blue (6 h incubation). 
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  VIIITable 12: Assessment of the morphological features seen by TEM after infection of 
J774.2 cells with different bacteria. J774.2 cells were mixed with bacterial strains at a 
MOI of 1:500. Cells were then centrifuged at 1000 x g for five min immediately after 
exposure to bacteria and incubated for 2 h. After removal of most of the extracellular 
bacteria by centrifugation and washing, the J774.2 cells were resuspended in fresh RPMI 
complete medium and incubated for a further 2 h before fixation of samples for TEM. 
For each strain, 100 individual J774.2 cells were examined. Cells were assessed to be 
dead if the cell membrane was discontinuous or ruptured. 
 
A. Percentage of cells showing vacuoles, intracellular bacteria, dead cells 
and bacteria free in the cytoplasm of J774.2 cells with different strains of 
bacteria.  
B. Break down of numbers of intracellular P. multocida B:2 strain 85020 
bacteria within 100 individual J774.2 cells at 4 h after challenge. 
 
 
 
 
 
 
 
 
 
 
 
 
  IXA:  
Treatments   Vacuolation of 
J774.2 cells  
Percentage of cells 
showing  vacuolation 
Intracellular 
survival 
Percentage of J774.2 cells 
with 
intracellular bacteria 
Dead 
cells 
Percentage 
of dead 
cells 
Percentage of cells 
with free bacteria 
in the cytoplasm  
P. m B+J774.2 cells  Observed   10%  Observed  28%  Observed 11%  8% 
P. mA+J774.2 cells  ----  ----            ---- ---- ---- ---- ----
E. coli +J774.2 cells ----  ----  ----        ---- ----  ---- ----
RPMI medium+J774.2   ----              ---- ---- ---- ---- ---- ----
---- not observed  P. m B Pasteurella multocida B:2 strain 85020    P. mA : Pasteurella multocida A :3      E. coli XL1-
Blue 
B:  
No of P. multocida B:2 85020 bacteria within individual  J774.2 cells   Total number of cells 
1          9  
2          2  
3          6  
4          1  
5          2  
6          3  
  I
8          1   
cytoplasm was observed (Figure 6C) which might have escaped from the vacuoles. 
Approximately 8% of the J774.2 cells examined showed intracellular bacteria free in the 
cytoplasm (Table 12A). Sometimes vacuoles were seen to contain multiple bacteria 
(Figures 6 A, H, Table 12B), which may have been the result of several bacteria being 
engulfed at the same time. Therefore, after 6 h of infection, consistent numbers of 
bacteria were found within phagosomes (Figure 6 H) and vacuolation was a prominent 
feature with J774.2 cells after treatment with P. multocida B:2 (Figures 6, B, C, G). This 
features were but was not apparent following treatment with P. multocida A:3 or E. coli 
XL1-Blue.  
 
3.5.2 BL-3 cell micrography 
    As can be seen in the TEM analysis presented in Figure 7, P. multocida B:2 was 
located  within BL-3 cells after 4 or 6 h. In similar experiments with P. multocida A:3 
and E. coli XL1-Blue, attached bacteria were observed,  but no intracellular bacteria 
were seen. Many extracellular bacteria were found, most of them being associated with 
the cell membrane and, in some instances, extracellular bacterial division was observed 
(Figures 7 B and G). An assessment of the morphological features is given in Table 13. 
Vacuolation was not seen to any significant extend with BL-3 cells after treatment with 
any of the bacteria but, instead evidence of a more general damage to the cytoplasm, 
creating large vacuole-like areas was more apparent (Figure 7 A, B, C, E, F, G, K, L) 
with all bacteria. Clear membrane disintegration of these mammalian cells was found 
(Figure 7, B, H, I). This was not seen with BL-3 cells that had been exposed to the 
bacteria (Figure 7D, H). Thus, TEM observations indicated that exposure of BL-3 host 
cells to all three bacterial species was associated with extensive cell damage.  
 
  IFigure 7: Electron micrographs of BL-3 cells infected at a MOI of 500:1 with P. 
multocida B:2 strains 85020, P. multocida serogroup A:3 or E.coli XL1-Blue. Cells 
were centrifuged at 1000 x g for 5 min and incubated for 2 h. Removal of most 
extracellular bacteria by centrifugation and washing was then performed. The BL-3 cells 
were treated with antibiotics (gentamicin and polymyxin, each at 350 µg/ml final 
concentration) for 2 h then antibiotics were removed by washing and samples taken for 
TEM at 4 h (A-F),or 6 h (G-L). The main features to note are localization of intracellular 
bacteria and apparent extensive cell damage. Non-internalised bacteria were also 
detected. 
A- P. multocida B:2 strain 85020 within vacuoles of  BL-3 cells (4 h incubation).    
Note the appearance of BL-3 cell damage.  
C-   BL-3 cells treated with P. multocida B:2 showing a damaged cell (4 h 
incubation) and evidence of dividing bacteria (arrowed).   
D- P. multocida B:2 strain 85020 (arrowed) free within cytoplasm (4 h incubation). 
The BL-3 cell appears damaged. 
E-  Normal appearance of BL-3 cell without bacteria (4 h incubation). 
F-  BL-3 cell treated with P. multocida A:3 (4 h incubation). The BL-3 cell appears 
damaged 
G- BL-3 cell treatment with E. coli XL1-Blue (4 h incubation). The BL-3 cell 
appears damaged 
H- Localization of P. multocida B:2 cell (arrow 1) within a BL-3 cell (6 h 
incubation). Extracellular bacteria were also present (arrow 2). 
I-  Damaged BL-3 cell, treated with P. multocida B:2 (6 h incubation).  
J-  Damaged BL-3 cell after treatment with the P. multocida B:2 (6 h incubation). 
K- Untreated BL-3 cell (6 h incubation). 
L-  BL-3 cell after treatment with P. multocida A:3 (6 h incubation). 
      L- BL-3 cell  after treatment with of E. coli strain XL1-Blue (6 h incubation). 
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   In conclusion, the action of P. multocida B:2 on both cell types resulted in some 
morphological changes with apparent cell damage particularly seen in the BL-3 cells 
(Table 13). Vacuolation was a prominent feature with J774.2 cells. Electron microscopy 
appeared to confirm the ability of P. multocida B:2 to survive intracellularly in that the 
morphology of the intracellular bacteria was normal. The results obtained with the 
control  P. multocida A:3 and E. coli XL1-Blue suggested that they not capable of 
invasion, but merely attach to the eukaryotic cell membrane in high numbers (Tables 12 
and 13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  IX 
CHAPTER 4 
4. Discussion:  
    Although P. multocida B:2  has been identified to cause HS in cattle or buffaloes, the 
manner in which P. multocida B:2 causes HS disease remains unclear. In particular, the 
rapid spread of infecting bacteria from the respiratory tract to the blood and lymph, 
characterized by oedematous swelling of the head and neck and swollen haemorrhagic 
lymph nodes, is a notable feature of HS. An important stage in the pathogenesis of 
infection by P. multocida is the translocation through epithelial tissue to the pulmonary 
interstitium. The potential to adhere to and invade cells may constitute a mechanism that 
enables the bacteria to invade the blood stream. A marker-free aroA deletion derivative 
(strain JRMT12) was constructed from an HS-associated P. multocida serotype B:2 
strain 85020 obtained from Sri Lanka. Tabatabaei et al. (2002) suggested that the aroA 
derivative of the P. multocida B:2 strain may be an excellent candidate for an attenuated 
live vaccine against HS. It was subsequently shown that intramuscular injection in 
calves of 10
7, 10
8 or 10
9 CFU twice at a 4-week interval of the aroA strain JRMT12 
completely protected calves against challenge with the virulent parent 85020 strain 
(Hodgson  et al., 2005; Dagleish et al., 2007). In this study, it was shown that P. 
multocida B:2 85020 and JRMT12 strains could enter and survive for at least 2 h in 
macrophage-like J774.2 and bovine lymphoma cells BL-3. The fact that, in our 
experiments, the HS strains of P. multocida could invade and survival in mammalian 
cells whereas P. multocida A:3 and E. coli XL1-Blue, although able to adhere to 
macrophages and BL-3 cells to a similar extent as the P. multocida B:2 strains, had a 
much reduced invasive capacity, is in accordance with the manner in which the P. 
multocida B:2 strains become rapidly bacteraemic in the host whereas P. multocida A:3 
  Xserotype disease is not characterized by this property. Whether this has any safety 
implication for the aroA vaccine strain remains to be determined. The attenuated strain 
is cleared from calves rapidly, but the possibility of intracellular survival for a longer 
period requires further investigation.  
 
4.1 Bacterial adherence and entry into the host cells 
4.1.1 Adherence of bacteria  
    Attachment is a primary prerequisite for bacterial infection of a host and ligands that 
are involved in such adherence are potential virulence factors. Several studies have 
examined the adherence of different P. multocida isolates to different cell types; tissues 
or organs and this often reflected serogroup-specific host preference and pathogenicity.  
 
    P. multocida serotype A:3 was found in association with the mucosal epithelium of 
the nasopharynges of rabbits with respiratory tract infections (Glorioso et al., 1982). The 
bacteria specifically attached to squamous epithelial cells of the pharyngeal mucosa both 
in  vivo and in  vitro and to some tissue culture cell lines such as HeLa cells. The 
attachment to pharyngeal and HeLa cells was inhibited by N-acetyl-D-glucosamine. 
These findings suggested that this amino sugar may be a component of the receptor on 
both animal cell surfaces and that the fimbriae may be the adhesins (Glorioso et al., 
1982). Esslinger et al. (1994) reported that P. multocida strains of serotype A adhered 
strongly to HeLa cells and to alveolar macrophages from rabbits, rats, mice, cattle and 
horses. The adhesions were markedly reduced by pre-treatment of the Pasteurella with 
hyaluronidase or pre-incubation of the HeLa cells with hyaluronic acid. This indicated a 
possible role of hyaluronic acid (contained in the capsules of serotype A strains) in 
adhesion and subsequent colonization of the bacteria (Esslinger et al., 1994).  
  XI 
    In vitro experiments were undertaken to study the adhesion to tracheal mucosa, lung 
and aorta explants from freshly killed rabbits of two different strains of P. multocida. 
Serotype A:3 and serotype D:1 strains isolated from a dead rabbit with septicaemia, 
were used (Al-Haddawi et al., 2000). When the explants were observed under the 
scanning electron microscope, the type D strain was more highly adhering to trachea and 
aorta explants compared to the type A strain. Adhesion to lung explants was best 
achieved by the type A strain after incubation for 45 min but, after incubation for 2 h, no 
significant difference was observed between the strains. The capsular material of P. 
multocida type A strain and the toxin of the type D strain were thought to influence the 
adherence to lung tissue in the rabbit. Adhesion of strain D to aorta may indicate the 
expression of receptors on the endothelium to that strain and may also explain the ability 
of certain strains to cause septicaemia (Al-Haddawi et al., 2000).  
 
    P. multocida serogroups A, D and B:2 strains are known to possess type IV fimbriae 
(designated PtfA (Ruffolo et al., 1997; Dabo et al., 2007). Under microaerophilic 
conditions P. multocida showed an increased expression of the fimbriae, which were 
observed to form bundles. Fimbriae purified by high-performance reverse-phase liquid 
chromatography constituted a single 18-kDa subunit, the first 21 amino acids of which 
shared very high similarity with the N-terminal amino acid sequence of type 4 fimbrial 
subunits from other bacteria. Antiserum against the P. multocida 18-kDa protein 
immuno-stained the type 4 fimbrial subunit of Moraxella bovis and Dichelobacter 
nodosus. Based on these observations, P. multocida possessed type 4 fimbriae and the P. 
multocida fimbrial subunit was designated PtfA. A later study was carried out to isolate 
and characterize the gene (ptfA) encoding type 4 fimbrial protein from P. multocida 
serogroup B:2 (Siju et al., 2007). Among the surface components of P. multocida, type 4 
  XIIfimbriae are considered important because they frequently mediate colonization of host 
surfaces. Thus, attachment by fimbriae to host surfaces is usually correlated with 
virulence (Siju et al., 2007).  
 
    E. coli has been shown to adhere to human epithelial HEp-2 cells (Zepeda-Lopez and 
Gonzalez-Lugo, 1995) and E. coli strains K12, MS101 and HB101 exhibited adhesion to 
in vitro-cultivated HEp-2 cells but did not have the capacity for invasion (Stehling et al., 
2008).  
 
        Many pathogens including members of the family Pasteurellaceae exploit host 
extracellular matrix (ECM) molecules for virulence through adherence and colonization. 
The adherence of clinical Haemophilus influenzae strains to immobilized extracellular 
matrix components has been examined. The strains showed a very high level of 
adherence to laminin and type I collagen, as well as adhesion to fibronectin (Bresser et 
al., 2000). Another study demonstrated that the interaction of Streptococcus pyogenes 
fibronectin-binding protein (SfbI) with fibronectin on non-phagocytic human epithelial 
HEp-2 cells triggered bacterial internalization (Molinari et al., 1997). Blocking of the 
Sfbl adhesin by antibodies either against the whole protein or against the fibronectin-
binding domains of SfbI, as well as pre-treatment of HEp-2 cells with purified SfbI 
protein, prevented both S. pyogenes attachment and internalization. It was also 
demonstrated that SfbI was enough to trigger the internalization process, as inert latex 
beads pre-coated with the purified SfbI protein were ingested. Experiments performed 
with a recombinant SfbI protein encompassing the two fibronectin-binding regions of 
the SfbI molecule demonstrated that these binding regions are essential and sufficient to 
activate uptake by HEp-2 cells. These results demonstrated that the fibronectin-binding 
protein SfbI was involved in both S. pyogenes attachment to and ingestion by HEp-2 
  XIIIcells and contributed to the elucidation of the underlying molecular events leading to 
eukaryotic cell invasion by S. pyogenes (Molinari et al., 1997).  
 
    The broad host range characteristics of P. multocida A:3 suggests recognition of host 
cell surface components (ECM molecules) common to multiple animal species and 
tissue types. Recent studies investigated the binding of P. multocida A to ECM 
molecules and showed that bovine P. multocida isolates bind to several ECM molecules 
including fibronectin (Fn) (Dabo et al., 2005). Bacteria bound both soluble and 
immobilized Fn and preferentially bound the N-terminal heparin-binding fragment (Hep-
1) of Fn, similar to that described for other bacterial pathogens (Dabo et al., 2005). The 
P. multocida A proteins identified as putative Fn-binding proteins include P. multocida 
OmpA, the TonB-dependent receptor HgbA (hemoglobin-binding protein A) and the 
transferrin-binding protein A (TbpA). P. multocida OmpA bound Madin–Darby bovine 
kidney (MDBK) via heparin and/or Fn bridging (Dabo et al., 2003). P. multocida A 
regulatory genes have also been reported as potential virulence factors: DNA adenine 
methylase (Dam) and the Rci recombinase (rci) gene.  In Salmonella typhi, Rci protein 
inverted the DNA in the C-terminal region of the type IV pili, resulting in the inhibition 
of the minor pilus protein expression (Morris et al., 2003). Whether Rci of P. multocida 
has a similar action on the bacterium type IV pili is unknown. The dam gene regulates 
the expression of virulence genes in several Gram-negative bacteria including P. 
multocida (Heusipp et al., 2007). 
    Two serotype A:3,4 strains of P. multocida that differed in virulence in turkeys were 
examined for their ability to invade epithelial cell monolayers grown in tissue culture 
(Lee et al., 1994). Both organisms were comparably adherent to cells of turkey kidney 
origin. However, the virulent strain (86-1913) penetrated primary turkey kidney 
epithelial cell monolayers at 10 times the level of the low-virulence vaccine strain. The 
  XIVvirulent strain was also able to invade porcine epithelial cells (PK15) and feline 
epithelial cells (CRFK) in cell culture. Neither organism invaded rabbit epithelial cells 
(RK13). Invasion of turkey cells was prevented by inhibition of bacterial protein or 
RNA synthesis but not by pre-treatment of the monolayers with periodate, trypsin, or 
neuraminidase. Invasion might be a mechanism of pathogenicity for this organism, 
contributing to colonization or virulence (Lee et al., 1994).  
 
    Adherence studies with a capsulated strain of P. multocida A:3 and turkey air sac 
macrophages in culture showed that the bacteria were capable of adhering in large 
numbers to the macrophages but were not internalized (Pruimboom et al., 1996). A 
noncapsulated variant of the serotype A:3 strain showed little or no adherence and was 
not internalized. These data indicated that the adhesive properties were caused by the 
presence of the capsule on the bacteria. The role of capsular hyaluronic acid in this 
adherence to macrophages was investigated. Depolymerization of the bacterial capsule 
with hyaluronidase increased phagocytosis by macrophage cultures, and addition of 
hyaluronic acid to the macrophages inhibited bacterial adherence. However, exposure of 
macrophages to chondroitin sulphate B, an anionic polysaccharide similar to hyaluronic 
acid, did not affect the adhesive properties and resistance to phagocytosis of capsulated 
organisms. Treatment of macrophages with sodium metaperiodate or trypsin suppressed 
bacterial binding. Collectively, these data indicate that P. multocida adhesion to air sac 
macrophages, but not internalization, was mediated by capsular hyaluronic acid and 
suggested that recognition of this bacterial polysaccharide is a result of a specific 
glycoprotein receptor.  
 
    In a study by Galdiero et al. (2001), confluent bovine aortic endothelial cells (BAEC) 
were infected with P. multocida serotype B and P. haemolytica serotype A:1 at ratios of 
  XVinfection of 10, 50, 100 or 1000 bacteria/cell. After keeping cells and bacteria in contact 
for 30 or 60 min at 4ºC, an association assay was carried out. The infected cells were 
fixed with methanol and cell association of bacteria was visualized by Giemsa staining. 
The results indicated no significance differences in adherence between the two species 
of absence at the different bacteria/cell ratios (Galdiero et al., 2001). In our studies, in 
the observe of killing of extracellular bacteria (by omitting gentamicin and polymyxin) 
the number of intracellular plus adherent bacteria of different strains of P. multocida 
B:2,  P. multocida A:3 and E coli XL1-Blue with J774.2 and BL-3 cells could be 
determined. By comparison with the number of intracellular bacteria (by using 
gentamicin and polymyxin) the number of adherent bacteria could then be assessed. 
After incubation for 2 or 4 h with J774.2 cells, the number of adherent P. multocida B:2 
JRMT12 was consistently approximately 2-fold higher than P. multocida B:2 85020 
(Tables 5 and 6) with or without a centrifugation step to bring the bacteria and 
mammalian cells into close contact. When the adherence of P. multocida B:2 JRMT12 
was compared with that of  P. multocida A:3 and E. coli XL1-Blue, it was again 
approximately 2-fold higher (Table 8). With BL-3 cells, the number of adherent bacteria 
were lower, and P. multocida B:2 strain 85020 appeared to adhere better than the mutant 
strain (Table 10). Adherence of strain JRMT12 to BL-3 cells was comparable to that of 
P. multocida A:3 whereas E. coli XL1-Blue appeared to adhere better (Table 11). 
However, these experiments would need to be repeated to confirm these differences. 
Therefore, BL-3 cells generally showed a reduced adherence of bacteria as compared to 
J774.2 cell lines. This may be explained due to the fact that the J774.2 is a macrophage 
like cell line and may be more able to attach and ingest bacteria, as compared to BL-3 
cells, which is a lymphoma cell line. These results suggested that variation in the 
number of the adherent bacteria in the vitro system depends on the surface 
characteristics of both the mammalian cell lines and the bacteria. With regard to the two 
  XVIP. multocida B:2 strains, the  difference in adhesion reflect some modification in the 
surface properties associated with altered aromatic acid biosynthesis.  
 
    For  many  pathogens,  adherence  and/or invasion involve association with host 
extracellular matrix molecules such as fibronectin (Fn) (Dabo et al., 2005). Fn bound to 
P. multocida A and inhibited its adherence to Madin-Darby bovine kidney cells, 
suggesting the involvement of Fn in the adherence of the bacterium to host cells. By 
comparison, soluble Fn bound less to the E. coli JM 109 control. In further experiment 
with the P. multocida B:2 strain, it would be of interest to determine the effect of Fn on 
their adherence to J774.2 and HeLa cells.  
 
4.1.2 Invasion of J774.2 cells. 
     Internalisation  of  P. multocida B:2 was detected 4 or 6 h after infection of 
mammalian cells by TEM and viable bacteria could be recovered from within these 
cells, by plate counts. Pathogenic bacteria such as Listeria monocytogenes and species of 
Salmonella,  Shigella and Yersinia are capable of inducing non-phagocytic cells to 
internalise them by a process termed invasion. This process involves adherence of the 
pathogen to the host cell followed by bacterial internalization into a membrane bound 
vacuole. The mechanisms of internalization are supplied by the host cell and involve 
cytoskeletal rearrangements and engulfment of the attached bacteria. (see interaction 
section 1.4). Internalization does not necessarily follow bacterial adherence to the host 
cell, as many bacteria which are capable of adherence to host cell surfaces are not 
invasive (Rosenshine and Finlay, 1993). However, in bacteria such as Salmonella and 
Shigella flexeneri, invasiveness is encoded by multiple gene systems which promote 
invasion by interacting with eukaryotic transmembrane proteins (Rosenshine and Finlay, 
1993). Also Salmonella invasion is associated with a transient increase of the inositol 
  XVIIphosphate concentration in the host cell cytoplasm (Ruschkowski et al., 1992; Brett and 
Cossart, 1997). These results indicate that S. typhimurium may activate host cell 
phospholipase C activity to form inositol phosphates which in turn stimulate release of 
intracellular calcium stores to facilitate bacterial uptake. With HeLa cells, S. 
typhimurium invasion is initiated shortly after bacterial addition to the cells, reaching a 
maximal invasion rate after about 10 min, and saturating the uptake capacity of the host 
cells after 30 min. Invading salmonellae induce extensive rearrangement of host actin 
filaments and other cytoskeletal proteins, including actin, tallin, ezrin, α-actinin and 
tubulin (Rosenshine and Finlay, 1993). Invasion is associated with significant 
rearrangement of the host cytoskeleton, indicating that signals are transduced between 
the bacterium and the host cell cytoplasm, across the eukaryotic cell membrane.  
 
    Our study showed that P. multocida B:2 has the ability to adhere to and invade J774.2 
cells, using an invasion assay previously employed by Tabatabaei (2000), where a MOI 
of 500:1 was used. Using gentamicin and polymyxin, we showed in this study that P. 
multocida B:2 can invade and survive within both J774.2 and BL-3 cell lines. Much of 
the knowledge regarding bacterial internalisation and intracellular survival has been 
gained from studies using an assay in which cultured mammalian cells are infected with 
bacteria for a pre-determined time. The cells recovered after antibiotic treatment to kill 
extracellular bacteria are presumed to be internalised within the cells. The preliminary 
killing assay with gentamicin and polymyxin at concentration of 350 µg/ml of each 
antibiotic revealed very similar killing profiles for both P. multocida B:2 strains with a 
rapid and significant decline in bacteria over a 2 h period. A combination of gentamicin 
and polymyxin together at the concentration of 350 µg/ml of each reduced the number of 
viable P. multocida B:2 bacteria  by >99.9% and essentially killed all bacteria. There 
was no significant difference in the susceptibility between two P. multocida B:2 strains 
  XVIIItested. Although the antibiotic assay seems to be a valuable test for measuring 
internalisation, it might not be suitable for long-term observation following 
internalisation as the antibiotics may be slowly taken up by the mammalian cells and, if 
they achieve sufficient concentration, may kill intracellular bacteria (see below). 
 
    Our data also demonstrated that P. multocida B:2 strains displayed an invasive ability 
for J774.2 cells that increased by up to an order of magnitude when bacteria cells were 
brought together by centrifugation, compared to when bacteria and cells were left simply 
to interact after mixing. This is likely to be due to the increased contact between the P. 
multocida B:2 cells and the surface receptors. The different invasion efficiencies of the 
P. multocida B:2 strains for J774.2 and BL-3 cells were likely due to a number of 
possible reasons including the fact that J774.2 cells are potentially phagocytic and the 
possibility of different interactions with cell surface receptors present on J774.2 and BL-
3 cells. P. multocida B:2 fimbriae have been reported to serve as the initial attachment 
point to host cells (Siju et al., 2007). However, after internalization, some pathogenic 
bacteria like P. multocida B:2 strains remain viable within eukaryotic vacuoles at least 
for 4 h post-infection. In contrast, other bacteria such as L. monocytogenese and S. 
flexneri lyse the vacuole membrane shortly after internalization, thereafter residing and 
multiplying in the cytoplasm. In the cytoplasmic vacuole, nutrients for bacteria may be 
limited. Moreover, in phagocytic cells such as macrophages, fusion of phagosomes with 
lysosomes exposes the intracellular bacteria to antibacterial factors such as proteolytic 
enzymes, low pH, oxidative radicals and antibacterial peptides (Rosenshine and Finlay, 
1993). S. flexneri  has several genes that are needed for protection against these factors 
(Brett and Cossart, 1997). In addition, S. typhimurium can inhibit phagosome lysosome 
fusion in macrophages (Buchmeier and Heffron, 1991). Although the mechanism 
responsible for inhibitiing phagosome-lysosome is unknown, this study suggested that 
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chain of LPS but required viable salmonellae. Intracellular survival of P. multocida B:2 
within macrophages and the fusion levels of phagocytic vesicles with lysosomes is 
recommended for future study.  
 
    With the intracellular assay using P. multocida B:2 strains, numbers of intracellular 
bacteria recovered at 4 h and at 6 h showed that, after washing J774.2 cells free of 
antibiotics, an apparent increase in bacterial counts was observed but, when a low level 
of antibiotics is maintained, fewer bacteria were recovered. It is difficult to interpret 
these data. If it is assumed that treatment with antibiotics at 350 µg/ml kills all 
extracellular bacteria, then the increase in intracellular bacterial counts between 4 and 6 
h in the absence of antibiotics would represent growth of the intracellular bacteria. If, 
however, it is assumed that the antibiotics at 350 µg/ml did not kill all extracellular 
bacteria and a small number remained viable, then the increase may simply have been 
due to the replication of these residual extracellular bacteria. In the presence of a low 
level of antibiotics (50 µg/ml) the intracellular count declined between 4 and 6 h. This 
could be interpreted in two ways. First, the low level of antibiotics prevented replication 
of residual extracellular bacteria and those within the cell did not replicate and slowly 
lost viability; second, antibiotics leakage into the mammalian cells began to kill 
intracellular bacteria and stopped their replication. In the first case, it could be concluded 
that the bacteria do not replicate within the mammalian cells and could survive 
intracellularly for a period of only a few hours. In the second case a capacity to replicate 
within the mammalian cells (indicated by an increase in intracellular bacteria counts in 
the absence of antibiotics) was interfered with by leakage of the antibiotics into the cells. 
 
  XX        Several groups working with other micro-organisms such as Rhodococcus equi 
(Hondalus and Mosser, 1994), Klebisella pneumoniae (Oelschlaeger and Tall, 1997), 
and  Mycobacterium tuberculosis (Mehta et al., 1996), have reported a continual 
decrease in recovered intracellular bacteria despite microscopic observations suggesting 
bacterial replication. Although aminoglycoside antibiotics such as gentamicin are 
generally thought to be unable to penetrate eukaryotic cell membranes, study showed 
they can enter macrophages and inactivate intracellular bacteria (Crowle et al., 1984; 
Drevets et al., 1994). For example, Drevets et al. (1994) reported that gentamicin caused 
normally non-bactericidal macrophages to kill Listeria monocytogenes and gentamicin 
caused listericidal cells to kill significantly more bacteria. This study also investigated 
whether lysates of macrophage hybrids cultured for 72 h in gentamicin-containing 
medium and then washed could kill Listeria cells. When cultured with 50 to 100 
micrograms of gentamicin per ml, cell lysates were extremely listericidal and showed 
the presence of intracellular gentamicin. It was believed that gentamicin does not 
penetrate cell membranes, and hypothesized that it can be internalized by the cell 
through pinocytosis and can enter the same intracellular compartment as does 
phagocytosed  L. monocytogenes. Macrophages, which had phagocytosed L. 
monocytogenes, were incubated with the fluorochrome lucifer yellow to trace 
pinocytosed medium. About half of the Listeria cells within the macrophages were 
surrounded by lucifer yellow, indicating delivery of pinocytosed fluid, which could 
contain antibiotics, to phagosomes containing bacteria. This experiment described that 
membrane-impermeant antibiotics can enter macrophages and kill intracellular bacteria. 
Thus, the use of gentamicin in macrophage bactericidal assays can interfere with the 
results and interpretation of experiments designed to study macrophage bactericidal 
activity (Drevets et al., 1994). Furthermore, bacterial infection with P. multocida B:2 
strains could cause mammalian cell lysis and release of intracellular bacteria into the 
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antibiotics and thus, despite their intracellular origin, they would not contribute to the 
recovered intracellular pool of bacteria. This is of particular concern where low level 
invasion or internalisation is being assayed using plate counts in the absence of 
antibiotics, as those bacteria designated as intracellular may in fact represent any 
extracellular survivors. This aspect is highlighted by the observation that internalised 
Actinobacillus actinomycetemcomitans bacteria could exit KB (human epidermoid 
carcinoma) cells and were found in the external environment soon after entry (Meyer et 
al., 1996).  
 
    Interestingly,  the  P. multocida B:2 85020 wild-type strain had an apparently 
decreased ability to be internalised by J774.2 cells compared to the P. multocida B:2 
JRMT12 (aroA) strain (Table 5). The reason for this is not clear, as both strains grew 
equally well in BHIB, but the colony morphology of the 85020 and JRMT12 strains 
differed slightly on BHIA. This may indicate some alteration in surface properties 
related to the defect in aromatic amino acid biosynthesis, and could be responsible for 
the differences in internalization. This possibility is all the more likely because, in 
general, JRMT12 was able to adhere to J774.2 cells better than the parent 85020 strain 
(Table 5). 
 
    The  number  of  P. multocida B:2 85020 wild type and JRMT 12 recovered after 
internalization was 50-100 fold greater than those recorded for the P. multocida serotype 
A:3 strain and this in turn exhibited 10-20 fold greater recovery than for E coli XL1-
Blue. It is clear from these data that the P. multocida B:2 serotype strains 85020 and 
JRMT12 had an invasive capacity that exceeded that of the P. multocida serotype A:3 
stain. This invasive capacity may be a virulence property which could potentially 
  XXIIexplain the enhanced capacity of P. multocida B:2 strains to translocate through the 
respiratory epithelium into the blood stream. Taking the E. coli XL1-Blue strain used in 
this study as a non-invasive control, it was clear also that the P. multocida A:3 strain had 
a better invasive capacity than E. coli XL1-Blue, although this was markedly reduced 
compared to the P. multocida B:2 strains. This may be relevant to the more non-invasive 
nature of disease caused by the P. multocida A:3 strains. The capacity of P. multocida to 
invade mammalian cells is in agreement with previous reports (see section 1.4.2), but the 
markedly better capacity of the P. multocida B:2 compared to the P. multocida A:3 
serotype has not been previously noted and is a novel finding. Although the J774.2 cell 
line is a mouse macrophage-like cell line, it dos not appear to be actively phagocytic 
since the P. multocida A:3 and E. coli XL1-Blue strains were only poorly taken up, 
according to the invasion assay, and not seen intracellulary by TEM. These finding 
support the suggestion that P. multocida B:2 is an invasive organism. 
 
4.1.3 Invasion of BL-3 cells 
     A previous study investigated the association and the invasion of a bovine aortic 
endothelial cell (BAEC) line by a P. multocida serotype B strain as a model for the 
possible intracellular survival during Pasteurella infections (Galdiero et al., 2001). The 
data suggested that P. multocida B was able to adhere to and to invade BAECs. 
Confluent BAEC monolayers were infected with bacteria at a ratio of infection of 10, 
50, 100 or 1000 bacteria per cell. The optimal bacteria/cells ratio was found to be 100/1, 
while the optimal infection time was approximately 4 h of incubation. In addition, 
bacterial internalization was dependent on microfilament and microtubule stability 
(Galdiero et al., 2001). The study used cytochalasin D, an inhibitor of actin 
polymerization, colchicine and nocodazole, inhibitors of microtubule formation, and 
taxol, which stabilizes the microtubules, to determine the involvement of microfilaments 
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reduced by 60%; in the presence of colchicine it was reduced by 97% and in the 
presence of nocodazole it was reduced to 95%. It can be concluded that invasion by P. 
multocida serotype B:2 involves active host cell involvement and demands further study.   
 
     The fate of P. multocida B:2 after interaction with BL-3 cells was determined in this 
study. As shown in Tables 8 and 9, both P. multocida B:2 85020 and its aroA mutant, 
strain JRMT12 were able to enter BL-3 cells and survive for at least 2 h. As with J774.2 
cells, the invasive capacity of the P. multocida B:2 85020 appeared to be slightly lower 
than the JRMT12 strain, but this difference was not significant. The invasive capacities 
of the P. multocida A:3 and E coli XL1-Blue strains were markedly lower than that of 
the  P. multocida B:2 strains. In fact, the invasion capacity of both P. multocida B:2 
strains for BL-3 cells was noticeably 20-30 fold higher than for P. multocida A:3 which 
was in turn 3-10 fold higher than for E. coli XL1-Blue. Generally, the invasion capacity 
of the bacteria for BL-3 cells was lower than that for J774.2 cells and the difference was 
probably a reflection of the reduced adherence of the bacteria to the BL-3 cells 
compared to the J774.2 cells. This is perhaps to be expected as J774.2 cells are a 
macrophage-like cell line and would be expected to attach to and ingest the bacteria 
more readily than the bovine lymphoma cell line 
 
4.2 TEM and mammalian cells  
     We found that P. multocida B:2 cells could be detected intracellularly in J774.2 and 
BL-3 cells at 4 h and 6 h post-invasion by transmission electron microscopy (TEM). The 
P. multocida B:2 strain was almost  always observed as individual cells or occasionally 
as group of cells inside membrane-bound cytoplasmic vacuoles and rarely in the 
cytoplasm of both cell lines. Electron micrographs of J774.2 cells often showed the 
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engulf them. The J774.2 and BL-3 cells were extensively altered by P. multocida B:2. In 
particular, J774.2 cells exhibited extensive vacuolation and, although some vacuoles 
contained bacteria, vacuolation was apparent without the presence of bacteria (Figure 6 
B, C, G, I). Vacuolation was less apparent with BL-3 cells, but in this case cell damage 
was more obvious (Figure 7 A, B, C, E, H, I) than with J774.2 cells (Figure 6 I). P. 
multocida A:3 and E. coli XL 1-Blue did not induce vacuolation in J774.2 cells, but 
appeared to induce cell damage to BL-3 cells in a manner similar to the P. multocida B:2 
strains (Figure 7 E, F, K, L). This was apparently associated with exposure to bacteria as 
cells appeared normal without exposure to bacteria. The TEM data, which showed 
apparent damage to BL-3 cells, was at variance to trypan blue exclusion data which 
showed that less of viability of BL-3 cells upon exposure to B:2 strains was minimal, 
loss than that observed for J774.2 cells (Figures 4 and 5). This is difficult to explain, 
although in the trypan blue experiments, cells were not exposed to antibiotics and there 
is the possibility that polymyxin and gentamicin, at the concentrations used, had 
detrimental effects on BL-3 cells in particular. In a previous study, dramatic effects on 
the appearance and viability of macrophages were observed (Shah et al., 1996).   
Macrophage were infected with P. multocida B:2, at an MOI of 10:1 bacteria: cells and 
macrophages were examined for cytotoxicity by EM (Shah et al., 1996). We believe that 
additional studies will be necessary to establish if P. multocida B:2 strains have 
cytotoxic activity towards mammalian cells. For example, J774A.1 macrophages were 
examined with Salmonella typhimurium and cytotoxicity was assessed by DNA staining 
with ethidium homodimer-1 which distinguishes; live from dead cells after incubation 
for 20 min. Ethidium homodimer-1 is a high affinity, membrane-impermeant dye that 
can only stain the DNA of the nucleus of dead cells (Chen et al., 1996). We failed to 
determine the cytotoxicity of bacteria to the J774.2 macrophage cells by MTT assay 
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al. (2001) assessed cytotoxicity by measuring release of lactic dehydrogenase from 
BAEC cells, but reported little or no cytotoxicity of their B serotype strain. However, 
Shah et al. (1996) reported cytotoxicity of P. multocida B:2,5 strain and indicated that 
this was due to the action of a toxin that caused vacuolation in RAW 264 macrophage 
cells. Our data also showed extensive vacuolation of J774.2 cells at 4 h post-infection 
with our B:2 85020 strain and is agreement with Shah et al. (1996). This was not 
apparent with the A:3 serotype strain (or E. coli) which is also is agreement with Shah et 
al. (1996) who showed vacuolation only occurred with their B:2 serotype. 
 
    Our  study  indicated  that  P. multocida B:2, like Salmonella flexneri and Listeria 
monocytogenes,  could occasionally  escape from the macrophage vacuoles and was 
found free in cytoplasm but more work would be needed to establish if this was an 
important feature of P. multocida behaviour. 
 
    Although vacuolation can be associated with phagocytic activity, a vacuolating toxin 
has been described in Helicobacter pylori (Cover et al., 1992). Vacuolation is first 
detectable in the cytoplasm of cells about 90 min after the addition of vacuolating 
cytotoxin (Cover et al., 1992). With H. pylori as the vacuoles increased in size, the 
vacuole membrane contained increasing quantities of rab7, a small cellular GTPase 
normally localized to late endosomal compartments. This suggested that the membrane 
of cytotoxin-induced vacuoles was derived at least in part from late endosomes. Total 
cellular levels of rab7 did not increase in vacuolated cells and, therefore, vacuolation 
was associated with redistribution of rab7 rather than increased production (Cover, 
1996). This finding suggested that alteration of membrane traffic within the cells may be 
important in the process of vacuole formation. Vacuolated cells were capable of 
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resulted in cell death (Cover, 1996). To assess whether P. multocida might encode a 
similar vacuolating toxin, homology was sought by alignment of protein sequences 
using BLAST (Basic Local Alignment Search Tool) for protein sequences between P. 
multocida A strain Pm70 genome sequences and vacuolating cytotoxin (VacA) of H. 
pylori strain J99 (see appendix 5.8). The database alignment measured a number of hits 
in the database of random sequences with the same distribution of amino acid as VacA. 
However, the score (bits) values indicated a poor alignment overall, with only a few 
short sequences showing some homology. These aligned regions were located mainly in 
the C-terminal region of VacA and it is possible that the B:2 strain produces one or more 
proteins with some homology to VacA in this region. 
 
     We  compared  interaction  of  P. multocida A:3 and E. coli XL1-Blue with both 
mammalian cell types, and found them to be less susceptible to these bacteria. 
Incubation of J774.2 cells with these bacteria did not produce any visible changes. No 
bacteria were detected inside the cells by TEM but many extracellular bacteria were 
detected which might have represented bacteria adherent to these cells. Our data 
demonstrated that E coli XL1-Blue adherence to these cells was low even compared to 
P. multocida A:3. No intracellular P. multocida A:3 or E. coli XL1-blue were detected 
intracellularly with BL-3 cells, but there was evidence of extensive cell damage. As 
discussed earlier, this may have been an artefact of BL-3 cell treatment.  
 
    In conclusion, this study explored whether P. multocida B:2 strains were internalized 
and could persist in mammalian cells. We used the ratio 500:1 P. multocida B:2 strains 
to J774.2, according to previous work by Tabatabaei (2000). Further work should 
establish the optimum ratio of bacteria: cells in order to achieve maximal invasion with 
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cells. This would be particularly important if, for example, a bovine epithelial cell line 
was studied in future work as being more relevant to the in vivo situation. Electron 
microscopy confirmed the presence of intracellular P. multocida B:2 bacteria. The 
number of internalized P. multocida B:2 bacteria was greater with J774.2 cells than with 
BL-3 cells. P. multocida A:3 and E. coli XL 1-Blue were found to bind significantly to 
J774.2 and BL-3 cells but were not internalised to any significant extent. The 
pathogenesis of HS strains is very complex and further investigations are necessary to 
improve our understanding of it. In addition, the recognition that the B:2 strains express 
the capacity to adhere and invade mammalian cells suggest that molecular studies to 
identify the components involved in these processes and the relevance of the vacuolating 
activity to pathogenesis may help to improve our understanding of the  pathogenicity of 
P. multocida B:2 strains.  
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5. Appendix: 
 
5.1 Brain heart infusion broth or agar    
Brain  heart  infusion  (Oxoid)       37.0  g 
Distilled  water        1000  ml 
The medium was dissolved in distilled water and sterilised by autoclaving 
for 20 min at 121°C. For solid medium, 1.2% (w/v) agar was added before 
autoclaving. Occasionally, 5% (v/v) sheep blood supplement was added 
(see below) to solid medium after it was allowed to cool to 50°C.  
 
5.2 Sheep blood agar (SBA) 
Blood agar base, dehydrated (Oxoid)     40 g 
Distilled  water       1000  ml 
The medium was dissolved in distilled water and brought to the boil to dissolve 
completely, then sterilised by autoclaving at 121ºC for 15 min, then 5% (v/v) sterile 
defibrinated sheep blood (B&E laboratories) was added after the medium was cooled to 
50ºC. The medium was mixed and poured into sterile petri dishes.  
 
5.3 Phosphate-buffered saline (PBS) 
NaCl     80  g 
KCl     2  g 
Na2HPO4.12H2O   14.3  g 
KH2PO4    2  g 
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at 121°C for 15 min and kept at 4°C. 
 
5.4 RPMI complete medium 
Heat-inactivated foetal bovine serum (FBS) (Gibco)   20 ml 
L-Glutamine  (Gibco)       1  ml 
Constituents were dissolved in up to 200 ml RPMI 1640 medium (Gibco) and stored at 
4°C. Antibiotics (penicillin and streptomycin) solution (Sigma) 1 ml was added as 
required. 
 
5.5 BL-3 medium 
L-15 Leibovitz medium (Gibco)      50 ml 
Heat-inactivated  FBS  (Gibco)     20  ml 
L-Glutamine  (Gibco)      2  ml 
Constituents were stored at 4°C. Antibiotics (penicillin and streptomycin) solution 
(Sigma) 1ml were added as required. 
 
5.6 Preparation of antibiotics solutions for invasion assay. 
Stock solutions of antibiotics (gentamicin 350mg/ml and polymyxin 350mg/ml)(Sigma) 
were dissolved in distilled H2O and filter sterilised by passing the solution through a 
filter of 0.2 µm pore size (Sartorius). All antibiotics solutions were stored at -20°C. 
 
 
 
 
  XXX5.7 Preparation of MTT dye solution  
To prepare MTT dye solution, 1.5 mg/ ml of MTT [3-(4,5-dimethylthiazo-2-yl)-2,5-
diphenyltetrazolium bromide] (Sigma) were dissolved in RPMI 1640 (Sigma) without 
phenol red and filter sterilized by passing to solution through a filter of 0.2 µm pore size 
just prior to adding it to the cells. The MTT solution was warmed to 37ºC for 10 min 
before use. 
 
5.8 Basic local alignment search tool (BLAST)  
Query ID :    lcl|1970 (VacA of Helicobacter Pylori) 
Description     None  
Molecule type     Amino acid  
Query Length   2902  
Database Name   Microbial/272843  
Description   Completed  Pasteurella multocida subsp. multocida 
strain. Pm70 proteins  
Program   BLASTP 2.2.18+ Citation  
Databas Descriptio Posted 
e  n  Date 
Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schäffer, Jinghui Zhang, 
Zheng Zhang, Webb Miller, and David J. Lipman (1997), "Gapped BLAST and PSI-
BLAST: a new generation of protein database search programs", Nucleic Acids Res. 
25:3389-3402. 
 
Reference  
  XXXI 
Description  
equences producing significant alignments:                          (Bits)   EValue 
f|NP_246656.1|  hypothetical protein PM1717 [Pasteurella multocida.….  28.1    4.6     
f|NP_245936.1|  hypothetical protein PM0999 [Pasteurella multocida ….. 27.7    6.0     
 
      Score 
S
 
ref|NP_246509.1|  Hsf [Pasteurella multocida subsp. multocida …………  32.0    0.32    
ref|NP_244996.1|  PfhB2 [Pasteurella multocida subsp. multocida……….  29.3    2.1     
ref|NP_245651.1|  Hsf [Pasteurella multocida subsp. multocida …….  ……28.9    2.7     
ref|NP_245470.1|  IspA [Pasteurella multocida subsp. multocida... …. ……28.5    3.5     
ref|NP_244994.1|  PfhB1 [Pasteurella multocida subsp. multocida... ……. ..28.5    3.5     
re
re
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